<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Asia Pac Allergy</journal-id><journal-id journal-id-type="publisher-id">APA</journal-id><journal-title-group><journal-title>Asia Pacific Allergy</journal-title></journal-title-group><issn pub-type="ppub">2233-8276</issn><issn pub-type="epub">2233-8268</issn><publisher><publisher-name>Asia Pacific Association of Allergy, Asthma and Clinical Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3269599</article-id><article-id pub-id-type="pmid">22348202</article-id><article-id pub-id-type="doi">10.5415/apallergy.2012.2.1.3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Current Review</subject></subj-group></article-categories><title-group><article-title>Infection, eosinophilia and childhood asthma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Chang-Keun</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Callaway</surname><given-names>Zak</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Fujisawa</surname><given-names>Takao</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Asthma &#x00026; Allergy Center, Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul 139-707, Korea.</aff><aff id="A2"><label>2</label>School of Biological Sciences, College of Natural Science, University of Ulsan, Ulsan 680-749, Korea.</aff><aff id="A3"><label>3</label>Clinical Research Institute, Mie Hospital, Tsu, Mie 514-0125, Japan.</aff><author-notes><corresp>
Correspondence: Zak Callaway. School of Biological Sciences, College of Natural Science, University of Ulsan 93 Daehak-ro, Nam-gu, Ulsan 680-749, Korea. Tel: +82-10-8098-7537, Fax: +82-52-259-2740, <email>zcall@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>31</day><month>1</month><year>2012</year></pub-date><volume>2</volume><issue>1</issue><fpage>3</fpage><lpage>14</lpage><history><date date-type="received"><day>23</day><month>10</month><year>2011</year></date><date date-type="accepted"><day>22</day><month>11</month><year>2011</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2012. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>There is a growing list of viruses and bacteria associated with wheezing illness and asthma. It is well known that a few of these pathogens are strongly associated with wheezing illness and asthma exacerbations. What is not known is if early childhood infections with these pathogens cause asthma, and, if so, exactly what are the pathophysiologic mechanisms behind its development. The current consensus is respiratory infection works together with allergy to produce the immune and physiologic conditions necessary for asthma diasthesis. One link between respiratory infection and asthma may be the eosinophil, a cell that plays prominently in asthma and allergy, but can also be found in the body in response to infection. In turn, the eosinophil and its associated products may be novel therapeutic targets, or at the very least used to elucidate the complex pathophysiologic pathways of asthma and other respiratory illnesses. Together or separately, they can also be used for diagnosis, treatment and monitoring. The optimal care of a patient must take into consideration not only symptoms, but also the underlying disease mechanisms.</p></abstract><kwd-group><kwd>Asthma</kwd><kwd>Eosinophilia</kwd><kwd>Eosinophil-derived neurotoxin</kwd><kwd>Infection</kwd><kwd>Respiratory virus</kwd><kwd>Wheezing</kwd></kwd-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>There is a dire need to understand the underlying pathophysiology of asthma, including the complex genetic and environmental influences, to develop more effective treatment strategies. Though the role of respiratory pathogens in asthma has been extensively studied over the past few decades, many questions remain unanswered. First, of the known pathogens, which are the most likely to cause an infection associated with recurrent wheezing/asthma development? Second, do early childhood infections with respiratory pathogens cause asthma or do they merely select those that are predisposed to these infections? Third, if they are a causal factor, what is the immunopathology behind it? In the following sections, the interactions between respiratory infections and asthma development/exacerbations will be explored, with an emphasis on those pathogens associated with eosinophilia.</p><sec><title>Infections in infancy and asthma development viral infection</title><p>It is well known that a substantial portion of infants who require hospitalization for bronchiolitis develop asthma by the age of 13 [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. The importance of early life infection has been highlighted by studies showing the timing of birth in relationship to the winter virus season can increase the risk of developing asthma by age 6 years by as much as 30% [<xref ref-type="bibr" rid="B6">6</xref>]. The exact mechanisms and pathophysiologic pathways by which infection leads to asthma are not known, and those that have been proposed are subject to intense debate. Risk factors for bronchiolitis include young age (especially &#x0003c;6 months), small lung size and exposure to tobacco smoke [<xref ref-type="bibr" rid="B7">7</xref>]. Despite the uncertainty, it is generally considered respiratory infection does not work alone, but rather synergistically with respiratory allergy to produce immunologic and physiologic conditions conducive to asthma development.</p><p>Respiratory syncytial virus (RSV) has been the main focus of research, and most infants will have had at least one infection with RSV by the age of three. This virus is the major cause of bronchiolitis in children &#x0003c;1 year of age; consequently, it is considered the most important respiratory tract pathogen of early childhood [<xref ref-type="bibr" rid="B8">8</xref>]. No direct interventional studies demonstrating a causal relationship between RSV and asthma have been published to date. However, a long-term study of over 95,000 children found that timing of birth in relationship to the winter virus peak (particularly RSV) independently predicted asthma development, with the highest risk estimated for those born 121 days (~4 months) before the peak [<xref ref-type="bibr" rid="B6">6</xref>]. In addition, the administration of anti-RSV immune globulin (palivizumab) to children at high risk of chronic airway disease improved lung function and reduced the incidence of asthma and atopy, suggesting the prevention of RSV infection has long-term effects on respiratory and immunologic parameters relevant to asthma development [<xref ref-type="bibr" rid="B9">9</xref>]. In a larger more recent study, palivizumab significantly reduced recurrent wheezing [<xref ref-type="bibr" rid="B10">10</xref>]. However, because nearly every child has been infected with RSV at least once, other genetic, environmental, and/or developmental factors must also contribute to the epidemiological link with childhood asthma [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>A number of recent papers have highlighted human rhinovirus's (HRV) possible role in asthma etiology. HRV is now recognized as an important cause of wheezing illness; however, it is most often found in asymptomatic infants and children [<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>]. The wide variety of illness severity may be due to either host factors (abnormal innate immune responses) [<xref ref-type="bibr" rid="B14">14</xref>] or virus strain (more virulent or pathogenic strains) [<xref ref-type="bibr" rid="B15">15</xref>]. In comparative studies, children with RV-induced bronchiolitis were older and more atopic [<xref ref-type="bibr" rid="B16">16</xref>], and had a more severe disease course in the acute phase [<xref ref-type="bibr" rid="B17">17</xref>] than children with RSV-induced bronchiolitis. In the Perth Birth Cohort study, HRV was the most common pathogen associated with an acute respiratory infection in the first year of life followed by RSV [<xref ref-type="bibr" rid="B18">18</xref>]. Another study found wheezing HRV illnesses during the first 3 years of life were associated with a nearly 10-fold increase in asthma risk at age 6 years [<xref ref-type="bibr" rid="B19">19</xref>]. In contrast, several studies suggest HRV infection is not a risk factor for asthma, but may instead reveal children predisposed to asthma due to abnormal lung physiology and/or immune responses [<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>].</p><p>Another virus that has been implicated as a possible cause of wheezing and asthma is human bocavirus (HBoV), a novel parvovirus first isolated in 2005 from the respiratory secretions of patients with pneumonia [<xref ref-type="bibr" rid="B22">22</xref>]. However, the link between HBoV and asthma, or even any respiratory disease, has been complicated by the fact that it has a high rate of co-infection [<xref ref-type="bibr" rid="B23">23</xref>]. A recent study conducted at Inje University Sanggye Paik Hospital, found an association between HBoV infection and acute wheezing in children [<xref ref-type="bibr" rid="B24">24</xref>]. In their epidemiological study on acute wheezing and children, HBoV (13.8%) was the third most frequently found virus after RV (33.3%) and RSV (13.8%). Another epidemiological study by Vallet et al. [<xref ref-type="bibr" rid="B25">25</xref>] found HBoV infection to be associated with 13% of severe asthma exacerbations in children. They suggested HBoV could play a major role in acute exacerbations in asthmatic children.</p><p>Other viral infections during infancy and early childhood causing lower respiratory infections are also associated with recurrent wheezing and asthma development. These include parainfluenza, influenza A and human metapneumovirus (HMPV) [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>]. In our recent study, we showed HMPV infection was associated with recurrent wheezing in children [<xref ref-type="bibr" rid="B28">28</xref>].</p></sec><sec><title>Bacterial infection</title><p>The role of bacterial infection in the pathogenesis of acute and chronic asthma remains quite controversial [<xref ref-type="bibr" rid="B29">29</xref>], and of the bacterial respiratory pathogens, the atypical bacteria <italic>Mycoplasma (M.) pneumoniae</italic> and <italic>Chlamydophila (C.) pneumoniae</italic> are the most commonly implicated. A 2011 study of 407 children under 5 years of age found <italic>M. pneumoniae</italic> and <italic>C. pneumoniae</italic> in approximately 10% and 2% of acute respiratory tract infections, with <italic>M. pneumoniae</italic> being associated with more severe disease including hospitalization for bronchiolitis [<xref ref-type="bibr" rid="B30">30</xref>]. In a follow-up study of 50 children with a previous history of <italic>M. pneumoniae</italic>, 23 suffered from recurrent wheezy bronchitis or asthma, including 5 who developed wheeze for the first time [<xref ref-type="bibr" rid="B31">31</xref>]. Case reports of chronic asthma beginning with <italic>M. pneumoniae</italic> infection also suggest this pathogen is a potential causative agent of asthma [<xref ref-type="bibr" rid="B32">32</xref>].</p><p>It has been suggested that chronic bacterial infection or colonization with pathogenic bacteria could eventually lead to asthma. In Bisgaard et al.'s study [<xref ref-type="bibr" rid="B33">33</xref>], they found that neonates colonized in the hypopharyngeal region with <italic>Streptococcus pneumoniae</italic>, <italic>Haemophilus influenzae</italic> or <italic>Moraxella catarrhalis</italic> (or a combination of them), but not <italic>Staphylococcus (S.) aureus</italic>, were at increased risk for recurrent wheeze and asthma by 5 years of age. However, other studies have shown an association between <italic>S. aureus</italic> and atopic diseases such as dermatitis, rhinitis and asthma [<xref ref-type="bibr" rid="B34">34</xref>-<xref ref-type="bibr" rid="B36">36</xref>]. More specifically, staphylococcal enterotoxin exposure has been associated with the pathogenesis of asthma and/or atopic dermatitis [<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B39">39</xref>]. A high prevalence of <italic>C. pneumoniae</italic> infection in school-age children with wheezing has also been found [<xref ref-type="bibr" rid="B40">40</xref>].</p><p>The mounting data detailing the strong association between respiratory viral/bacterial infection and asthma suggests further studies are needed to clearly demonstrate causality. An alternative mechanism may be that individuals with a tendency toward atopy may have increased susceptibility to bacterial and viral infections and an increased risk of asthma development [<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>]. The question of whether early childhood infections cause asthma, or instead cause chronic disease in those with an underlying predisposition to asthma, remains unanswered.</p></sec><sec><title>Infection and asthma exacerbations</title><p>It has been estimated that nearly 85% of asthma exacerbations in children, and nearly 50% in adults, are a result of viral infections [<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>]. Indeed, with the advent of nucleic acid amplification testing (e.g., reverse transcription-polymerase chain reaction) and immunoassays, the detection of HRV and other RNA viruses has been enhanced suggesting HRV may be responsible for a larger proportion of exacerbations than previously thought. In a study by Rakes et al. [<xref ref-type="bibr" rid="B45">45</xref>], HRV was the predominant pathogen (71%) in children aged 2-16 presenting to emergency departments with acute wheezing, while only 6% were positive for RSV. A study of 206 asthmatic children aged 3-18 found HRV (26%) as the most common cause of exacerbation [<xref ref-type="bibr" rid="B46">46</xref>], while in adults, HRV was again the most common pathogen (56% of virus-positive specimens) found in asthma-related acute-care visits [<xref ref-type="bibr" rid="B47">47</xref>]. These studies provide strong evidence of the association between respiratory viral infection and asthma exacerbation. However, it is still unclear whether viral infection alone can exacerbate asthma, or if other factors, such as exposure to allergens [<xref ref-type="bibr" rid="B48">48</xref>] or air pollution [<xref ref-type="bibr" rid="B49">49</xref>], work synergistically to precipitate an attack.</p><p>Several studies have also demonstrated an association between atypical bacterial infection and asthma exacerbation. <italic>C. pneumoniae</italic> has been implicated in severe chronic asthma [<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>] and both <italic>C. pneumoniae</italic> and <italic>M. pneumoniae</italic> have been linked to acute asthma exacerbation in children and adults [<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>]. In a recent study [<xref ref-type="bibr" rid="B54">54</xref>], 22 of 58 (39%) patients presenting with acute exacerbation of bronchial asthma were found to be infected with either <italic>C. pneumoniae</italic>, <italic>M. pneumoniae</italic> or both, and those with atypical infection had greater functional impairment on admission when compared to patients with non-atypical respiratory infection.</p><p>The body's response to an invading pathogen includes the respiratory, immune and nervous systems [<xref ref-type="bibr" rid="B55">55</xref>]. Respiratory infections during infancy may have acute and long-term effects on lung and immune system development, and represent a risk factor for asthma development. When bronchial epithelial cells are infected by a pathogen (<xref ref-type="fig" rid="F1">Fig. 1</xref>), they generate both local and systemic immune responses aimed at clearing the infection. Neural signals are also generated to coordinate inflammation. In the asthmatic individual, however, immune response is altered and bronchial epithelial cells are damaged. A damaged bronchial epithelial lining is more susceptible to penetration by environmental irritants, which can directly stimulate sensory nerves leading to increased histamine release from mast cells and induction of smooth muscle cell contraction (i.e., bronchoconstriction) by released kinins [<xref ref-type="bibr" rid="B56">56</xref>]. A number of mediators are released by infected bronchial epithelial cells and play a role in recruiting major inflammatory cells, such as eosinophils, neutrophils and mast cells, though these cells may already be present in asthmatic airways. Eosinophils can be recruited to inflammatory sites by cytokines (most notably the T-helper type 2 (Th2) cell-derived IL-4, IL-5, and IL-13), and chemokines CCL5/RANTES and CCL11/eotaxin-1 [<xref ref-type="bibr" rid="B57">57</xref>], while neutrophils are most likely recruited by CXCL8/IL-8 or LTB4 [<xref ref-type="bibr" rid="B58">58</xref>]. Mast cells can, in turn, be activated by eosinophil-derived major basic protein (MBP) to release a number of mediators [<xref ref-type="bibr" rid="B59">59</xref>]. Together, these major inflammatory cells release mediators that can cause airway hyperresponsiveness (AHR), airway remodeling (through the action of eosinophils, fibrogenic and growth factors), and airway limitation (bronchoconstriction, mucosal edema, hypersecretion), leading to characteristic asthma exacerbation symptoms (wheeze, dyspnea, cough, chest tightness).</p><p>Eosinophils are generally considered as major effector cells of asthma, and it has long been thought that the eosinophilic response to viral infection has a predominantly negative effect on human health, that it is the major cause of inflammation responsible for tissue damage, bronchoconstriction and respiratory dysfunction [<xref ref-type="bibr" rid="B60">60</xref>]. However, several studies have shown eosinophils may promote viral clearance and antiviral host defense. This concept, termed the "double-edged sword", was first introduced by Smith [<xref ref-type="bibr" rid="B61">61</xref>] in 1994, with respect to the dual role of neutrophils in viral infection. Rosenberg and Domachowske [<xref ref-type="bibr" rid="B62">62</xref>-<xref ref-type="bibr" rid="B64">64</xref>] followed with their hypothesis that eosinophils may be recruited in part to promote primary antiviral host defense, possibly in situations where acquired immune response was less than effective [<xref ref-type="bibr" rid="B65">65</xref>]. More specifically, through their secretory mediators, eosinophils could reduce the infectivity of RSV for target epithelial cells <italic>in vitro</italic>. More recently, Phipps et al. [<xref ref-type="bibr" rid="B66">66</xref>] demonstrated accelerated clearance of RSV from murine lungs, and that full antiviral activity was dependent on intact TLR signaling in eosinophils introduced exogenously.</p><p>The clinical course of <italic>Mycoplasma</italic> pneumonia is typically mild and self-limited; however, long-term complications can occur via three possible mechanisms. According to a study by Kim et al. [<xref ref-type="bibr" rid="B67">67</xref>], 14 of 38 (37%) children hospitalized with <italic>Mycoplasma</italic> pneumonia had abnormal high-resolution computed tomography findings (i.e., mosaic perfusion, bronchiectasis, bronchial wall thickening, air trapping, and Swyer-James Syndrome) suggestive of small airway obstruction. Long-term complications may also occur due to immune modulation. Koh et al. [<xref ref-type="bibr" rid="B68">68</xref>] found increased IL-4 levels and IL-4/interferon (IFN)-&#x003b3; ratios in patients with <italic>Mycoplasma</italic> pneumonia. The data suggested a predominant Th2-like cytokine response, thus representing a favorable condition for IgE production that may result in the release of chemical mediators leading to bronchospasm, airway inflammation, and airway hyperresponsiveness. A third possible mechanism by which <italic>M. pneumoniae</italic> infection can lead to long-term complications is through functional abnormalities. Pulmonary function test results, such as decreased flow rate at 50% of vital capacity [<xref ref-type="bibr" rid="B39">39</xref>], have been reported. Furthermore, <italic>M. pneumoniae</italic> infection has been associated with bronchial hyperresponsiveness [<xref ref-type="bibr" rid="B69">69</xref>]. Long-term impairment of small airways function has also been noted in studies by Mok et al. [<xref ref-type="bibr" rid="B31">31</xref>], Sabato et al. [<xref ref-type="bibr" rid="B70">70</xref>] and several others.</p></sec><sec><title>Infection and the hygiene hypothesis</title><p>Early childhood exposure to certain pathogens may actually be protective against atopy and/or asthma, termed the "hygiene hypothesis" [<xref ref-type="bibr" rid="B71">71</xref>]. This highly controversial idea was borne from early observations showing the risk of developing allergy and/or asthma was inversely related to the number of children in the family [<xref ref-type="bibr" rid="B72">72</xref>]. However, this seems paradoxical, as it is also known that bronchiolitis and pneumonia in infancy lead to an increased risk of subsequent asthma. Whether infections have a protective effect or not may have to do with location, frequency, intensity, and timing [<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>].</p><p>Another possible mechanism for the switch to an atopic phenotype has been proposed; namely, a defect in the stimulation of dendritic cells by nonpathogenic microorganisms in gut-associated lymphoid tissue leading to reduced production of regulatory T cells [<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>]. Differences in gut bacteria colonization have been reported in children with atopic dermatitis. For example, <italic>Enterococci</italic> and <italic>Bifidobacteria</italic> were reduced, while <italic>Clostridia</italic> and <italic>S. aureus</italic> were increased [<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>]. These changes have been partly associated with the increased use of antibiotics [<xref ref-type="bibr" rid="B34">34</xref>].</p><p>Other environmental factors influence the development of atopic sensitization, including early exposure to pets and an agricultural background [<xref ref-type="bibr" rid="B79">79</xref>]. In an agricultural setting, increased exposure to high levels of endotoxin has been associated with lower rates of allergy and an elevated IFN-producing cells in the blood [<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>], cells which are known for their potent antiviral activity [<xref ref-type="bibr" rid="B82">82</xref>]. Taken one step further, Schaub et al. [<xref ref-type="bibr" rid="B83">83</xref>] demonstrated maternal exposure to farming decreases the risk of allergic disease in offspring, possibly through the increased number and activation of T-regulatory cord blood cells associated with lower Th2 cytokine secretion and lymphocyte proliferation on innate exposure. Indeed, there is growing evidence, both in human and animal studies, that pre- and post-natal exposure to pathogens and allergens may provide a protective effect against allergy development. In addition, breastfeeding has been shown to protect against asthma and lower respiratory illness, especially RSV [<xref ref-type="bibr" rid="B84">84</xref>, <xref ref-type="bibr" rid="B85">85</xref>].</p></sec><sec><title>Infection and atopy</title><p>One paramount question that remains unanswered in determining the link between early childhood infection and asthma development is: Do respiratory infections merely select those individuals that are predisposed to asthma, or are these infections able to alter lung development/immune response enough to actually cause asthma? A number of studies have shown that respiratory allergy may play a potentially synergistic role with viral/bacterial infections to produce airway inflammation and subsequent asthma in childhood [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B84">84</xref>]. One recent cohort study by Kusel et al. [<xref ref-type="bibr" rid="B20">20</xref>] found only an association between viral infections during infancy and subsequent development of persistent wheeze and asthma at 5 years in children with atopic sensitization during the first 2 years of life. This association was also restricted to infections that spread to the lower respiratory and were intense enough to cause severe symptoms in the infants. Together, respiratory allergy and infection can cause airway dysfunction through several mechanisms, including: viral infection damaging barrier function of the airway epithelium, leading to enhanced absorption of aeroallergens [<xref ref-type="bibr" rid="B86">86</xref>], and the generation of various cytokines, chemokines, leukotrienes, and molecules that may further upregulate cellular recruitment, cell activation, and the continuing inflammatory response [<xref ref-type="bibr" rid="B56">56</xref>].</p></sec><sec><title>The role of eosinophilia in asthma development/exacerbation</title><p>Eosinophilic inflammation is a cardinal feature of asthma and increases in eosinophilic inflammatory markers have been shown to be good predictors of asthma exacerbations [<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>]. It has been demonstrated that suppression of eosinophilic inflammation with glucocorticosteroids is associated with an amelioration of symptoms and airway dysfunction [<xref ref-type="bibr" rid="B89">89</xref>]. A recent study by Fanat et al. [<xref ref-type="bibr" rid="B90">90</xref>] found anti-IL-5 treatment reduced the eosinophilopoietic potential of airway smooth muscle cells, suggesting it may promote in situ eosinophilopoiesis in asthmatic lungs. Furthermore, Haldar et al. [<xref ref-type="bibr" rid="B91">91</xref>] and Nair et al. [<xref ref-type="bibr" rid="B92">92</xref>] demonstrated the ability of anti-IL-5 therapy in reducing eosinophil numbers while improving asthma control in refractory eosinophilic asthma.</p></sec><sec><title>Eosinophils as effector cells</title><p>Eosinophils are major effector cells of the allergic process. Activation of eosinophils leads to extracellular release of a number of granule proteins, such as eosinophil cationic protein (ECP), eosinophil-derived neurotoxin (EDN), MBP, and eosinophil peroxidase (refer to <xref ref-type="fig" rid="F1">Fig. 1</xref>) [<xref ref-type="bibr" rid="B93">93</xref>]. Among the many mediators released during eosinophil activation and degranulation, it is these eosinophil granule proteins that are the most strongly implicated in the pathophysiology of asthma [<xref ref-type="bibr" rid="B94">94</xref>]. Eosinophils also release a number of proinflammatory cytokines, chemokines and lipid mediators. In addition, eosinophils express a large number of cell-surface markers, including adhesion and apoptotic signaling molecules, chemokine, complement and chemotactic factor receptors, and cytokine, immunoglobulin, prostaglandin, platelet activating factor, and leukotriene receptors [<xref ref-type="bibr" rid="B95">95</xref>-<xref ref-type="bibr" rid="B99">99</xref>].</p><p>Eosinophils have generally been regarded as terminal effector cells in allergic airway diseases; however, recent studies demonstrate their involvement in the initial stages of allergic disease development, as well [<xref ref-type="bibr" rid="B100">100</xref>]. Murine studies suggest eosinophils may actually drive T-cell responses as opposed to merely being driven by them. Eosinophils can act as antigen-presenting cells [<xref ref-type="bibr" rid="B101">101</xref>, <xref ref-type="bibr" rid="B102">102</xref>]; thus, at disease onset they are able to induce activation and proliferation and/or cytokine production in T cells.</p></sec><sec><title>Viral infection and eosinophilia</title><p>To further elucidate the connection between early childhood viral infection and asthma development, several studies involving RSV bronchiolitis have been carried out due to the clinical analogy, epidemiologic relationship, and similar immunologic phenomena in the airways, such as specific IgE production [<xref ref-type="bibr" rid="B103">103</xref>], generation of chemokines [<xref ref-type="bibr" rid="B104">104</xref>] and adhesion molecules [<xref ref-type="bibr" rid="B105">105</xref>], and eosinophil activation [<xref ref-type="bibr" rid="B106">106</xref>] it shares with childhood asthma. A number of studies have demonstrated eosinophilia during/post RSV bronchiolitis [<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B106">106</xref>-<xref ref-type="bibr" rid="B110">110</xref>]. However, the downfall of many RSV studies is the lack of premorbid eosinophil levels. Therefore, it cannot be explicitly stated that the observed eosinophilia was a result of RSV infection. Indeed, prenatal Th2/Th1 imbalance, allergic sensitization during pregnancy or some other reason may result in elevated eosinophil levels in infants. This was suggested in a study by Frischer et al. [<xref ref-type="bibr" rid="B111">111</xref>] of neonates born to atopic parents.</p><p>Though most viral infections are thought to be neutrophilic in nature, studies by our research group have shown a subgroup of RSV bronchiolitis patients is eosinophil-positive [<xref ref-type="bibr" rid="B107">107</xref>]. This subgroup also had higher levels of Th2 cytokines. Eosinophilia together with a skewed Th2 cytokine response strongly resembles the immunologic profile of childhood asthma. To further strengthen the relationship between RSV bronchiolitis and asthma, our research group recently undertook a RSV bronchiolitis study [<xref ref-type="bibr" rid="B106">106</xref>] investigating eosinophil degranulation post-bronchiolitis and its association with recurrent wheezing. We found good correlations between the eosinophil degranulation marker, EDN, and recurrent wheezing episodes in a cohort of infants with a first episode of RSV bronchiolitis. Furthermore, EDN levels at 3 months proved to have predictive value for recurrent wheezing (positive predictive value = 57%, negative predictive value = 76%, sensitivity = 72%, specificity = 62%). Indeed, it appears there is a subgroup of RSV bronchiolitis patients with marked eosinophilia that may go on to later develop asthma. This hypothesis may help elucidate the link between early childhood infections and asthma development.</p></sec><sec><title>Bacterial infection and eosinophilia</title><p>One connection between bacterial infection and asthma pathogenesis may be the eosinophil. An <italic>in vivo</italic> study found patients with acute bacterial infection exhibited increased levels of serum ECP levels [<xref ref-type="bibr" rid="B112">112</xref>]. The authors concluded that eosinophils are activated during acute bacterial infections and that this activation results in the preferential release of ECP. Another study [<xref ref-type="bibr" rid="B113">113</xref>] found elevated ECP levels (&#x0003e;200 ng/mL) in all 16 patients presenting with acute community-acquired bacterial sinusitis, and 10 of those 16 had remarkably elevated ECP levels (&#x0003e;3,000 ng/mL). It should be noted that these patients had no history of chronic sinusitis, active or chronic allergies, or any other chronic upper respiratory disease. An <italic>in vitro</italic> study found pathogenic bacteria induced EDN release by eosinophils [<xref ref-type="bibr" rid="B114">114</xref>], and in a murine model, staphylococcal enterotoxin B induced eosinophilic airway inflammation and evidence of eosinophil degranulation [<xref ref-type="bibr" rid="B115">115</xref>].</p><p>Elevated levels of ECP have been associated with the increased activation of eosinophils [<xref ref-type="bibr" rid="B116">116</xref>]; hence, ECP is thought to reflect the activation state of eosinophils [<xref ref-type="bibr" rid="B117">117</xref>]. The immunologic benefits of eosinophil activation and ECP release may include antibacterial activity in concentrations 10-20 &#x000b5;g/mL and above [<xref ref-type="bibr" rid="B118">118</xref>, <xref ref-type="bibr" rid="B119">119</xref>]. It has been speculated that due to its stability, ECP may accumulate over time in mucus fluids and act as a first line of defense against bacterial invasion [<xref ref-type="bibr" rid="B120">120</xref>].</p></sec><sec><title>Asthma phenotypes</title><p>A number of techniques have recently been used to characterize the myriad of asthma phenotypes in hopes of better tailoring treatment to the individual. The classical IgE-associated allergic asthma phenotype (also termed 'extrinsic') starting in childhood is the most widely studied, as it is the most common in real-life and easily studied in the clinical laboratory. In allergic asthma, the cytokine profile is predominantly Th2 (i.e., IL-4, IL-5, IL-9, and IL-13). A recent genome microarray study by Woodruff et al. [<xref ref-type="bibr" rid="B121">121</xref>] found significant IL-13-mediated gene induction in asthma. One genetic biomarker in particular was associated with eosinophil accumulation in the airways, while another was identified as a potential mediator of corticosteroid-resistant asthma. Other studies, including the one by Martin et al. [<xref ref-type="bibr" rid="B122">122</xref>], have vetted other predictive markers, such as IgE and blood eosinophil levels, serum eosinophil degranulation protein levels, lung function, and PC<sub>20</sub> [<xref ref-type="bibr" rid="B123">123</xref>]. These examples highlight the need for careful consideration of phenotypes, especially variable treatment responses, when treating asthma patients.</p><p>The less common 'intrinsic' asthma is of late-onset, lacks circulating specific IgE, and no sensitivities to allergens can be identified [<xref ref-type="bibr" rid="B57">57</xref>]; despite this, airway eosinophilia and Th2 cells feature prominently [<xref ref-type="bibr" rid="B124">124</xref>]. Intrinsic asthma is less common (~10%) than extrinsic asthma, is more common in females, and tends to be more severe, requiring higher doses of corticosteroids [<xref ref-type="bibr" rid="B125">125</xref>]. Clinically, however, intrinsic asthma shares a great deal with extrinsic asthma, including variable airflow obstruction and symptoms, and a good therapeutic response to corticosteroid therapy. It is well established that upper respiratory tract viral infections are the most common cause of exacerbations in intrinsic and extrinsic asthma [<xref ref-type="bibr" rid="B126">126</xref>].</p><p>In addition to eosinophilic inflammation, other cardinal features of most asthmatic phenotypes include AHR, excessive airway mucus production, and airway remodeling [<xref ref-type="bibr" rid="B57">57</xref>].</p></sec><sec><title>Eosinophils and asthma</title><p>Eosinophil increases in the tissues, body fluids (e.g., sputum, peripheral blood, serum, bronchoalveolar lavage) and bone marrow have been noted in asthma [<xref ref-type="bibr" rid="B107">107</xref>, <xref ref-type="bibr" rid="B127">127</xref>, <xref ref-type="bibr" rid="B128">128</xref>]. These elevated levels have correlated well with disease severity, leading to the hypothesis that the eosinophil is the major effector cell of asthma. One way in which they act as major effector cells is through the release of granule proteins, which induce tissue damage and dysfunction [<xref ref-type="bibr" rid="B129">129</xref>], as well as the further propagation of airway inflammation. Elevated levels of ECP [<xref ref-type="bibr" rid="B130">130</xref>] and EDN [<xref ref-type="bibr" rid="B131">131</xref>] have been noted in asthmatics, with higher levels of ECP [<xref ref-type="bibr" rid="B132">132</xref>] and EDN [<xref ref-type="bibr" rid="B133">133</xref>] found during asthma exacerbation when compared to healthy patients and those with stable asthma. This would suggest airway inflammation associated with asthma exacerbation is characterized not only by an increase in number of eosinophils, but also an increase in airway eosinophil degranulation [<xref ref-type="bibr" rid="B134">134</xref>].</p></sec><sec><title>Monitoring of asthma with eosinophil markers</title><p>Though eosinophils are important in the pathophysiology of asthma, eosinophil degranulation and its associated products, such as EDN and ECP, may be even more important. It has been suggested that the secretory activity of eosinophils - a combination of concentration of eosinophils and their propensity to release degranulation products - may be a key marker of disease activity and is more accurately measured by eosinophil degranulation products such as EDN and ECP [<xref ref-type="bibr" rid="B135">135</xref>]. Kim et al. [<xref ref-type="bibr" rid="B136">136</xref>] found significant differences in EDN and ECP levels in asthmatics during both acute and stable phases when compared to controls. Thus, EDN, along with ECP, may aid in the diagnosis of asthma. It has been suggested by several groups that EDN is more useful than ECP in evaluating disease severity [<xref ref-type="bibr" rid="B136">136</xref>-<xref ref-type="bibr" rid="B138">138</xref>]. This may partially be due to EDN's recoverability, as ECP is a sticky and more highly charged protein [<xref ref-type="bibr" rid="B129">129</xref>].</p><p>In terms of clinical utility, EDN levels are a more accurate biomarker of the underlying pathophysiology of asthma (i.e., eosinophilic inflammation); consequently, they provide an objective measure of the eosinophil's secretory activity. In children too young to fully participate in lung function tests, EDN levels may be useful as an alternative measurement of eosinophilic inflammation, but larger studies should be carried out to determine its reproducibility and repeatability for this purpose.</p></sec></sec><sec><title>CONCLUSION</title><p>Viral and bacterial infections are important causes of childhood respiratory disease. They can lead to long-term morbidity, such as recurrent wheezing, and evidence points toward a very strong link between early childhood infection and asthma development. However, the underlying pathophysiologic link between infection and chronic allergic disease is still not fully understood. With increased understanding and attention to these disease processes, clinicians will better be able to diagnose, treat and monitor asthma. Indeed, focus must shift from not only treating symptoms, but also the underlying pathophysiology to provide optimal care to the patient.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>This work was supported in part by a 2011 Inje University Research Grant.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigurs</surname><given-names>N</given-names></name><name><surname>Gustafsson</surname><given-names>PM</given-names></name><name><surname>Bjarnason</surname><given-names>R</given-names></name><name><surname>Lundberg</surname><given-names>F</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Sigurbergsson</surname><given-names>F</given-names></name><name><surname>Kjellman</surname><given-names>B</given-names></name></person-group><article-title>Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>171</volume><fpage>137</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">15516534</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>J</given-names></name><name><surname>Hilliard</surname><given-names>TN</given-names></name><name><surname>Sherriff</surname><given-names>A</given-names></name><name><surname>Stalker</surname><given-names>D</given-names></name><name><surname>Al Shammari</surname><given-names>N</given-names></name><name><surname>Thomas</surname><given-names>HM</given-names></name></person-group><article-title>Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study</article-title><source>Pediatr Allergy Immunol</source><year>2005</year><volume>16</volume><fpage>386</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">16101930</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>RT</given-names></name><name><surname>Sherrill</surname><given-names>D</given-names></name><name><surname>Morgan</surname><given-names>WJ</given-names></name><name><surname>Holberg</surname><given-names>CJ</given-names></name><name><surname>Halonen</surname><given-names>M</given-names></name><name><surname>Taussig</surname><given-names>LM</given-names></name><name><surname>Wright</surname><given-names>AL</given-names></name><name><surname>Martinez</surname><given-names>FD</given-names></name></person-group><article-title>Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years</article-title><source>Lancet</source><year>1999</year><volume>354</volume><fpage>541</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">10470697</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotaniemi-Syrj&#x000e4;nen</surname><given-names>A</given-names></name><name><surname>Vainionp&#x000e4;&#x000e4;</surname><given-names>R</given-names></name><name><surname>Reijonen</surname><given-names>TM</given-names></name><name><surname>Waris</surname><given-names>M</given-names></name><name><surname>Korhonen</surname><given-names>K</given-names></name><name><surname>Korppi</surname><given-names>M</given-names></name></person-group><article-title>Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma?</article-title><source>J Allergy Clin Immunol</source><year>2003</year><volume>111</volume><fpage>66</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12532098</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>FD</given-names></name></person-group><article-title>Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma</article-title><source>Pediatr Infect Dis J</source><year>2003</year><volume>22</volume><fpage>S76</fpage><lpage>S82</lpage><pub-id pub-id-type="pmid">12671456</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Dupont</surname><given-names>WD</given-names></name><name><surname>Griffin</surname><given-names>MR</given-names></name><name><surname>Carroll</surname><given-names>KN</given-names></name><name><surname>Mitchel</surname><given-names>EF</given-names></name><name><surname>Gebretsadik</surname><given-names>T</given-names></name><name><surname>Hartert</surname><given-names>TV</given-names></name></person-group><article-title>Evidence of a causal role of winter virus infection during infancy in early childhood asthma</article-title><source>Am J Respir Crit Care Med</source><year>2008</year><volume>178</volume><fpage>1123</fpage><lpage>1129</lpage><pub-id pub-id-type="pmid">18776151</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>FD</given-names></name><name><surname>Wright</surname><given-names>AL</given-names></name><name><surname>Taussig</surname><given-names>LM</given-names></name><name><surname>Holberg</surname><given-names>CJ</given-names></name><name><surname>Halonen</surname><given-names>M</given-names></name><name><surname>Morgan</surname><given-names>WJ</given-names></name></person-group><article-title>Asthma and wheezing in the first six years of life</article-title><source>N Engl J Med</source><year>1995</year><volume>332</volume><fpage>133</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">7800004</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mcintosh</surname><given-names>K</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Kliegman</surname><given-names>RM</given-names></name><name><surname>Behrman</surname><given-names>RE</given-names></name><name><surname>Jenson</surname><given-names>HB</given-names></name><name><surname>Stanton</surname><given-names>BF</given-names></name><name><surname>Nelson</surname><given-names>WE</given-names></name></person-group><article-title>Respiratory syncytial virus</article-title><source>Nelson textbook of pediatrics</source><year>2007</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Saunders</publisher-name><fpage>1388</fpage><lpage>1390</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>SE</given-names></name><name><surname>Gibbs</surname><given-names>RL</given-names></name><name><surname>Lehr</surname><given-names>MV</given-names></name><name><surname>Simoes</surname><given-names>EA</given-names></name></person-group><article-title>Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin</article-title><source>Am J Med</source><year>2002</year><volume>112</volume><fpage>627</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">12034412</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoes</surname><given-names>EA</given-names></name><name><surname>Groothuis</surname><given-names>JR</given-names></name><name><surname>Carbonell-Estrany</surname><given-names>X</given-names></name><name><surname>Rieger</surname><given-names>CH</given-names></name><name><surname>Mitchell</surname><given-names>I</given-names></name><name><surname>Fredrick</surname><given-names>LM</given-names></name><name><surname>Kimpen</surname><given-names>JL</given-names></name></person-group><article-title>Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing</article-title><source>J Pediatr</source><year>2007</year><volume>151</volume><fpage>34</fpage><lpage>42</lpage><fpage>42.e1</fpage><pub-id pub-id-type="pmid">17586188</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemanske</surname><given-names>RF</given-names><suffix>Jr</suffix></name></person-group><article-title>Viral infections and asthma inception</article-title><source>J Allergy Clin Immunol</source><year>2004</year><volume>114</volume><fpage>1023</fpage><lpage>1026</lpage><pub-id pub-id-type="pmid">15536404</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemanske</surname><given-names>RF</given-names><suffix>Jr</suffix></name><name><surname>Jackson</surname><given-names>DJ</given-names></name><name><surname>Gangnon</surname><given-names>RE</given-names></name><name><surname>Evans</surname><given-names>MD</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Shult</surname><given-names>PA</given-names></name><name><surname>Kirk</surname><given-names>CJ</given-names></name><name><surname>Reisdorf</surname><given-names>E</given-names></name><name><surname>Roberg</surname><given-names>KA</given-names></name><name><surname>Anderson</surname><given-names>EL</given-names></name><name><surname>Carlson-Dakes</surname><given-names>KT</given-names></name><name><surname>Adler</surname><given-names>KJ</given-names></name><name><surname>Gilbertson-White</surname><given-names>S</given-names></name><name><surname>Pappas</surname><given-names>TE</given-names></name><name><surname>Dasilva</surname><given-names>DF</given-names></name><name><surname>Tisler</surname><given-names>CJ</given-names></name><name><surname>Gern</surname><given-names>JE</given-names></name></person-group><article-title>Rhinovirus illnesses during infancy predict subsequent childhood wheezing</article-title><source>J Allergy Clin Immunol</source><year>2005</year><volume>116</volume><fpage>571</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">16159626</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>EK</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Erdman</surname><given-names>DD</given-names></name><name><surname>Poehling</surname><given-names>KA</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Griffin</surname><given-names>MR</given-names></name><name><surname>Hartert</surname><given-names>TV</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Weinberg</surname><given-names>GA</given-names></name><name><surname>Hall</surname><given-names>CB</given-names></name><name><surname>Iwane</surname><given-names>MK</given-names></name><name><surname>Edwards</surname><given-names>KM</given-names></name></person-group><article-title>Rhinovirus-associated hospitalizations in young children</article-title><source>J Infect Dis</source><year>2007</year><volume>195</volume><fpage>773</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">17299706</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>SL</given-names></name></person-group><article-title>Innate immunity in the pathogenesis of virus-induced asthma exacerbations</article-title><source>Proc Am Thorac Soc</source><year>2007</year><volume>4</volume><fpage>267</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">17607011</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>WM</given-names></name><name><surname>Kiesner</surname><given-names>C</given-names></name><name><surname>Pappas</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>I</given-names></name><name><surname>Grindle</surname><given-names>K</given-names></name><name><surname>Jartti</surname><given-names>T</given-names></name><name><surname>Jakiela</surname><given-names>B</given-names></name><name><surname>Lemanske</surname><given-names>RF</given-names><suffix>Jr</suffix></name><name><surname>Shult</surname><given-names>PA</given-names></name><name><surname>Gern</surname><given-names>JE</given-names></name></person-group><article-title>A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants</article-title><source>PLoS One</source><year>2007</year><volume>2</volume><fpage>e966</fpage><pub-id pub-id-type="pmid">17912345</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korppi</surname><given-names>M</given-names></name><name><surname>Kotaniemi-Syrj&#x000e4;nen</surname><given-names>A</given-names></name><name><surname>Waris</surname><given-names>M</given-names></name><name><surname>Vainionp&#x000e4;&#x000e4;</surname><given-names>R</given-names></name><name><surname>Reijonen</surname><given-names>TM</given-names></name></person-group><article-title>Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis</article-title><source>Pediatr Infect Dis J</source><year>2004</year><volume>23</volume><fpage>995</fpage><lpage>999</lpage><pub-id pub-id-type="pmid">15545853</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papadopoulos</surname><given-names>NG</given-names></name><name><surname>Moustaki</surname><given-names>M</given-names></name><name><surname>Tsolia</surname><given-names>M</given-names></name><name><surname>Bossios</surname><given-names>A</given-names></name><name><surname>Astra</surname><given-names>E</given-names></name><name><surname>Prezerakou</surname><given-names>A</given-names></name><name><surname>Gourgiotis</surname><given-names>D</given-names></name><name><surname>Kafetzis</surname><given-names>D</given-names></name></person-group><article-title>Association of rhinovirus infection with increased disease severity in acute bronchiolitis</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>165</volume><fpage>1285</fpage><lpage>1289</lpage><pub-id pub-id-type="pmid">11991880</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusel</surname><given-names>MM</given-names></name><name><surname>de Klerk</surname><given-names>NH</given-names></name><name><surname>Holt</surname><given-names>PG</given-names></name><name><surname>Kebadze</surname><given-names>T</given-names></name><name><surname>Johnston</surname><given-names>SL</given-names></name><name><surname>Sly</surname><given-names>PD</given-names></name></person-group><article-title>Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study</article-title><source>Pediatr Infect Dis J</source><year>2006</year><volume>25</volume><fpage>680</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">16874165</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>DJ</given-names></name><name><surname>Gangnon</surname><given-names>RE</given-names></name><name><surname>Evans</surname><given-names>MD</given-names></name><name><surname>Roberg</surname><given-names>KA</given-names></name><name><surname>Anderson</surname><given-names>EL</given-names></name><name><surname>Pappas</surname><given-names>TE</given-names></name><name><surname>Printz</surname><given-names>MC</given-names></name><name><surname>Lee</surname><given-names>WM</given-names></name><name><surname>Shult</surname><given-names>PA</given-names></name><name><surname>Reisdorf</surname><given-names>E</given-names></name><name><surname>Carlson-Dakes</surname><given-names>KT</given-names></name><name><surname>Salazar</surname><given-names>LP</given-names></name><name><surname>DaSilva</surname><given-names>DF</given-names></name><name><surname>Tisler</surname><given-names>CJ</given-names></name><name><surname>Gern</surname><given-names>JE</given-names></name><name><surname>Lemanske</surname><given-names>RF</given-names><suffix>Jr</suffix></name></person-group><article-title>Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children</article-title><source>Am J Respir Crit Care Med</source><year>2008</year><volume>178</volume><fpage>667</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">18565953</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusel</surname><given-names>MM</given-names></name><name><surname>de Klerk</surname><given-names>NH</given-names></name><name><surname>Kebadze</surname><given-names>T</given-names></name><name><surname>Vohma</surname><given-names>V</given-names></name><name><surname>Holt</surname><given-names>PG</given-names></name><name><surname>Johnston</surname><given-names>SL</given-names></name><name><surname>Sly</surname><given-names>PD</given-names></name></person-group><article-title>Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma</article-title><source>J Allergy Clin Immunol</source><year>2007</year><volume>119</volume><fpage>1105</fpage><lpage>1110</lpage><pub-id pub-id-type="pmid">17353039</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Message</surname><given-names>SD</given-names></name><name><surname>Laza-Stanca</surname><given-names>V</given-names></name><name><surname>Mallia</surname><given-names>P</given-names></name><name><surname>Parker</surname><given-names>HL</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Kebadze</surname><given-names>T</given-names></name><name><surname>Contoli</surname><given-names>M</given-names></name><name><surname>Sanderson</surname><given-names>G</given-names></name><name><surname>Kon</surname><given-names>OM</given-names></name><name><surname>Papi</surname><given-names>A</given-names></name><name><surname>Jeffery</surname><given-names>PK</given-names></name><name><surname>Stanciu</surname><given-names>LA</given-names></name><name><surname>Johnston</surname><given-names>SL</given-names></name></person-group><article-title>Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production</article-title><source>Proc Natl Acad Sci U S A</source><year>2008</year><volume>105</volume><fpage>13562</fpage><lpage>13567</lpage><pub-id pub-id-type="pmid">18768794</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allander</surname><given-names>T</given-names></name><name><surname>Tammi</surname><given-names>MT</given-names></name><name><surname>Eriksson</surname><given-names>M</given-names></name><name><surname>Bjerkner</surname><given-names>A</given-names></name><name><surname>Tiveljung-Lindell</surname><given-names>A</given-names></name><name><surname>Andersson</surname><given-names>B</given-names></name></person-group><article-title>Cloning of a human parvovirus by molecular screening of respiratory tract samples</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>12891</fpage><lpage>12896</lpage><pub-id pub-id-type="pmid">16118271</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allander</surname><given-names>T</given-names></name></person-group><article-title>Human bocavirus</article-title><source>J Clin Virol</source><year>2008</year><volume>41</volume><fpage>29</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">18055252</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>JY</given-names></name><name><surname>Han</surname><given-names>TH</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Hwang</surname><given-names>ES</given-names></name></person-group><article-title>Detection of viruses identified recently in children with acute wheezing</article-title><source>J Med Virol</source><year>2007</year><volume>79</volume><fpage>1238</fpage><lpage>1243</lpage><pub-id pub-id-type="pmid">17597481</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallet</surname><given-names>C</given-names></name><name><surname>Pons-Catalano</surname><given-names>C</given-names></name><name><surname>Mandelcwajg</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Raymond</surname><given-names>J</given-names></name><name><surname>Lebon</surname><given-names>P</given-names></name><name><surname>Gendrel</surname><given-names>D</given-names></name></person-group><article-title>Human bocavirus: a cause of severe asthma exacerbation in children</article-title><source>J Pediatr</source><year>2009</year><volume>155</volume><fpage>286</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">19619752</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro-Rodr&#x000ed;guez</surname><given-names>JA</given-names></name><name><surname>Holberg</surname><given-names>CJ</given-names></name><name><surname>Wright</surname><given-names>AL</given-names></name><name><surname>Halonen</surname><given-names>M</given-names></name><name><surname>Taussig</surname><given-names>LM</given-names></name><name><surname>Morgan</surname><given-names>WJ</given-names></name><name><surname>Martinez</surname><given-names>FD</given-names></name></person-group><article-title>Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study</article-title><source>Am J Respir Crit Care Med</source><year>1999</year><volume>159</volume><fpage>1891</fpage><lpage>1897</lpage><pub-id pub-id-type="pmid">10351936</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jartti</surname><given-names>T</given-names></name><name><surname>van den Hoogen</surname><given-names>B</given-names></name><name><surname>Garofalo</surname><given-names>RP</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Ruuskanen</surname><given-names>O</given-names></name></person-group><article-title>Metapneumovirus and acute wheezing in children</article-title><source>Lancet</source><year>2002</year><volume>360</volume><fpage>1393</fpage><lpage>1394</lpage><pub-id pub-id-type="pmid">12423987</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Callaway</surname><given-names>Z</given-names></name><name><surname>Kim</surname><given-names>HB</given-names></name><name><surname>Chung</surname><given-names>JY</given-names></name><name><surname>Koh</surname><given-names>YY</given-names></name><name><surname>Shin</surname><given-names>BM</given-names></name></person-group><article-title>Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in Seoul, Korea, 2003-2008</article-title><source>J Korean Med Sci</source><year>2010</year><volume>25</volume><fpage>342</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">20191030</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemanske</surname><given-names>RF</given-names><suffix>Jr</suffix></name></person-group><article-title>Is asthma an infectious disease?: Thomas A. Neff lecture</article-title><source>Chest</source><year>2003</year><volume>123</volume><fpage>385S</fpage><lpage>390S</lpage><pub-id pub-id-type="pmid">12628996</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezerra</surname><given-names>PG</given-names></name><name><surname>Britto</surname><given-names>MC</given-names></name><name><surname>Correia</surname><given-names>JB</given-names></name><name><surname>Duarte Mdo</surname><given-names>C</given-names></name><name><surname>Fonceca</surname><given-names>AM</given-names></name><name><surname>Rose</surname><given-names>K</given-names></name><name><surname>Hopkins</surname><given-names>MJ</given-names></name><name><surname>Cuevas</surname><given-names>LE</given-names></name><name><surname>McNamara</surname><given-names>PS</given-names></name></person-group><article-title>Viral and atypical bacterial detection in acute respiratory infection in children under five years</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e18928</fpage><pub-id pub-id-type="pmid">21533115</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mok</surname><given-names>JY</given-names></name><name><surname>Waugh</surname><given-names>PR</given-names></name><name><surname>Simpson</surname><given-names>H</given-names></name></person-group><article-title><italic>Mycoplasma pneumoniae</italic> infection. A follow-up study of 50 children with respiratory illness</article-title><source>Arch Dis Child</source><year>1979</year><volume>54</volume><fpage>506</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">485193</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname><given-names>T</given-names></name><name><surname>Ichikawa</surname><given-names>Y</given-names></name><name><surname>Komatu</surname><given-names>S</given-names></name><name><surname>Arai</surname><given-names>S</given-names></name><name><surname>Oizumi</surname><given-names>K</given-names></name></person-group><article-title>Association of <italic>Mycoplasma pneumoniae</italic> antigen with initial onset of bronchial asthma</article-title><source>Am J Respir Crit Care Med</source><year>1994</year><volume>149</volume><fpage>1348</fpage><lpage>1353</lpage><pub-id pub-id-type="pmid">8173777</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisgaard</surname><given-names>H</given-names></name><name><surname>Hermansen</surname><given-names>MN</given-names></name><name><surname>Buchvald</surname><given-names>F</given-names></name><name><surname>Loland</surname><given-names>L</given-names></name><name><surname>Halkjaer</surname><given-names>LB</given-names></name><name><surname>B&#x000f8;nnelykke</surname><given-names>K</given-names></name><name><surname>Brasholt</surname><given-names>M</given-names></name><name><surname>Heltberg</surname><given-names>A</given-names></name><name><surname>Vissing</surname><given-names>NH</given-names></name><name><surname>Thorsen</surname><given-names>SV</given-names></name><name><surname>Stage</surname><given-names>M</given-names></name><name><surname>Pipper</surname><given-names>CB</given-names></name></person-group><article-title>Childhood asthma after bacterial colonization of the airway in neonates</article-title><source>N Engl J Med</source><year>2007</year><volume>357</volume><fpage>1487</fpage><lpage>1495</lpage><pub-id pub-id-type="pmid">17928596</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>BS</given-names></name></person-group><article-title>The role of microorganisms in atopic dermatitis</article-title><source>Clin Exp Immunol</source><year>2006</year><volume>144</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16542358</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heaton</surname><given-names>T</given-names></name><name><surname>Mallon</surname><given-names>D</given-names></name><name><surname>Venaille</surname><given-names>T</given-names></name><name><surname>Holt</surname><given-names>P</given-names></name></person-group><article-title>Staphylococcal enterotoxin induced IL-5 stimulation as a cofactor in the pathogenesis of atopic disease: the hygiene hypothesis in reverse?</article-title><source>Allergy</source><year>2003</year><volume>58</volume><fpage>252</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">12653801</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>RE</given-names></name><name><surname>Monasterolo</surname><given-names>G</given-names></name></person-group><article-title>Prevalence of serum IgE antibodies to the <italic>Staphylococcus aureus</italic> enterotoxins (SAE, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis</article-title><source>Int Arch Allergy Immunol</source><year>2004</year><volume>133</volume><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">14976395</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachert</surname><given-names>C</given-names></name><name><surname>Gevaert</surname><given-names>P</given-names></name><name><surname>Howarth</surname><given-names>P</given-names></name><name><surname>Holtappels</surname><given-names>G</given-names></name><name><surname>van Cauwenberge</surname><given-names>P</given-names></name><name><surname>Johansson</surname><given-names>SG</given-names></name></person-group><article-title>IgE to <italic>Staphylococcus aureus</italic> enterotoxins in serum is related to severity of asthma</article-title><source>J Allergy Clin Immunol</source><year>2003</year><volume>111</volume><fpage>1131</fpage><lpage>1132</lpage><pub-id pub-id-type="pmid">12743582</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Ye</surname><given-names>YM</given-names></name><name><surname>Bahn</surname><given-names>JW</given-names></name><name><surname>Suh</surname><given-names>CH</given-names></name><name><surname>Nahm</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>HR</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name></person-group><article-title>Role of staphylococcal superantigen-specific IgE antibodies in aspirin-intolerant asthma</article-title><source>Allergy Asthma Proc</source><year>2006</year><volume>27</volume><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">17063661</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semic-Jusufagic</surname><given-names>A</given-names></name><name><surname>Bachert</surname><given-names>C</given-names></name><name><surname>Gevaert</surname><given-names>P</given-names></name><name><surname>Holtappels</surname><given-names>G</given-names></name><name><surname>Lowe</surname><given-names>L</given-names></name><name><surname>Woodcock</surname><given-names>A</given-names></name><name><surname>Simpson</surname><given-names>A</given-names></name><name><surname>Custovic</surname><given-names>A</given-names></name></person-group><article-title><italic>Staphylococcus aureus</italic> sensitization and allergic disease in early childhood: populationbased birth cohort study</article-title><source>J Allergy Clin Immunol</source><year>2007</year><volume>119</volume><fpage>930</fpage><lpage>936</lpage><pub-id pub-id-type="pmid">17292957</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>AF</given-names></name><name><surname>Johnston</surname><given-names>SL</given-names></name><name><surname>Julious</surname><given-names>SA</given-names></name><name><surname>Lampe</surname><given-names>FC</given-names></name><name><surname>Ward</surname><given-names>ME</given-names></name></person-group><article-title><italic>Chronic Chlamydia pneumoniae</italic> infection and asthma exacerbations in children</article-title><source>Eur Respir J</source><year>1998</year><volume>11</volume><fpage>345</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">9551736</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jartti</surname><given-names>T</given-names></name><name><surname>Korppi</surname><given-names>M</given-names></name><name><surname>Ruuskanen</surname><given-names>O</given-names></name></person-group><article-title>The clinical importance of rhinovirus-associated early wheezing</article-title><source>Eur Respir J</source><year>2009</year><volume>33</volume><fpage>706</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">19251814</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juhn</surname><given-names>YJ</given-names></name><name><surname>Kita</surname><given-names>H</given-names></name><name><surname>Yawn</surname><given-names>BP</given-names></name><name><surname>Boyce</surname><given-names>TG</given-names></name><name><surname>Yoo</surname><given-names>KH</given-names></name><name><surname>McGree</surname><given-names>ME</given-names></name><name><surname>Weaver</surname><given-names>AL</given-names></name><name><surname>Wollan</surname><given-names>P</given-names></name><name><surname>Jacobson</surname><given-names>RM</given-names></name></person-group><article-title>Increased risk of serious pneumococcal disease in patients with asthma</article-title><source>J Allergy Clin Immunol</source><year>2008</year><volume>122</volume><fpage>719</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">18790525</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>KG</given-names></name><name><surname>Kent</surname><given-names>J</given-names></name><name><surname>Ireland</surname><given-names>DC</given-names></name></person-group><article-title>Respirator y viruses and exacerbations of asthma in adults</article-title><source>BMJ</source><year>1993</year><volume>307</volume><fpage>982</fpage><lpage>986</lpage><pub-id pub-id-type="pmid">8241910</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>SL</given-names></name><name><surname>Pattemore</surname><given-names>PK</given-names></name><name><surname>Sanderson</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Lampe</surname><given-names>F</given-names></name><name><surname>Josephs</surname><given-names>L</given-names></name><name><surname>Symington</surname><given-names>P</given-names></name><name><surname>O'Toole</surname><given-names>S</given-names></name><name><surname>Myint</surname><given-names>SH</given-names></name><name><surname>Tyrrell</surname><given-names>DA</given-names></name><name><surname>Holgate</surname><given-names>ST</given-names></name></person-group><article-title>Community study of role of viral infections in exacerbations of asthma in 9-11 year old children</article-title><source>BMJ</source><year>1995</year><volume>310</volume><fpage>1225</fpage><lpage>1229</lpage><pub-id pub-id-type="pmid">7767192</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakes</surname><given-names>GP</given-names></name><name><surname>Arruda</surname><given-names>E</given-names></name><name><surname>Ingram</surname><given-names>JM</given-names></name><name><surname>Hoover</surname><given-names>GE</given-names></name><name><surname>Zambrano</surname><given-names>JC</given-names></name><name><surname>Hayden</surname><given-names>FG</given-names></name><name><surname>Platts-Mills</surname><given-names>TA</given-names></name><name><surname>Heymann</surname><given-names>PW</given-names></name></person-group><article-title>Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses</article-title><source>Am J Respir Crit Care Med</source><year>1999</year><volume>159</volume><fpage>785</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">10051251</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>TF</given-names></name><name><surname>To</surname><given-names>MY</given-names></name><name><surname>Yeung</surname><given-names>AC</given-names></name><name><surname>Wong</surname><given-names>YS</given-names></name><name><surname>Wong</surname><given-names>GW</given-names></name><name><surname>Chan</surname><given-names>PK</given-names></name></person-group><article-title>Multiplex molecular detection of respiratory pathogens in children with asthma exacerbation</article-title><source>Chest</source><year>2010</year><volume>137</volume><fpage>348</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">19749009</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atmar</surname><given-names>RL</given-names></name><name><surname>Guy</surname><given-names>E</given-names></name><name><surname>Guntupalli</surname><given-names>KK</given-names></name><name><surname>Zimmerman</surname><given-names>JL</given-names></name><name><surname>Bandi</surname><given-names>VD</given-names></name><name><surname>Baxter</surname><given-names>BD</given-names></name><name><surname>Greenberg</surname><given-names>SB</given-names></name></person-group><article-title>Respiratory tract viral infections in inner-city asthmatic adults</article-title><source>Arch Intern Med</source><year>1998</year><volume>158</volume><fpage>2453</fpage><lpage>2459</lpage><pub-id pub-id-type="pmid">9855383</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>RM</given-names></name><name><surname>Custovic</surname><given-names>A</given-names></name><name><surname>Sanderson</surname><given-names>G</given-names></name><name><surname>Hunter</surname><given-names>J</given-names></name><name><surname>Johnston</surname><given-names>SL</given-names></name><name><surname>Woodcock</surname><given-names>A</given-names></name></person-group><article-title>Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study</article-title><source>BMJ</source><year>2002</year><volume>324</volume><fpage>763</fpage><pub-id pub-id-type="pmid">11923159</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarlo</surname><given-names>SM</given-names></name><name><surname>Broder</surname><given-names>I</given-names></name><name><surname>Corey</surname><given-names>P</given-names></name><name><surname>Chan-Yeung</surname><given-names>M</given-names></name><name><surname>Ferguson</surname><given-names>A</given-names></name><name><surname>Becker</surname><given-names>A</given-names></name><name><surname>Rogers</surname><given-names>C</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Manfreda</surname><given-names>J</given-names></name></person-group><article-title>The role of symptomatic colds in asthma exacerbations: Influence of outdoor allergens and air pollutants</article-title><source>J Allergy Clin Immunol</source><year>2001</year><volume>108</volume><fpage>52</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">11447382</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>PN</given-names></name><name><surname>Scicchitano</surname><given-names>R</given-names></name><name><surname>Jenkins</surname><given-names>CR</given-names></name><name><surname>Blasi</surname><given-names>F</given-names></name><name><surname>Allegra</surname><given-names>L</given-names></name><name><surname>Wlodarczyk</surname><given-names>J</given-names></name><name><surname>Cooper</surname><given-names>BC</given-names></name></person-group><article-title>Serological evidence of infection with <italic>Chlamydia pneumoniae</italic> is related to the severity of asthma</article-title><source>Eur Respir J</source><year>2000</year><volume>15</volume><fpage>254</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">10706488</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Hertzen</surname><given-names>LC</given-names></name></person-group><article-title>Role of persistent infection in the control and severity of asthma: focus on <italic>Chlamydia pneumoniae</italic></article-title><source>Eur Respir J</source><year>2002</year><volume>19</volume><fpage>546</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">11936537</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>D</given-names></name><name><surname>Lieberman</surname><given-names>D</given-names></name><name><surname>Printz</surname><given-names>S</given-names></name><name><surname>Ben-Yaakov</surname><given-names>M</given-names></name><name><surname>Lazarovich</surname><given-names>Z</given-names></name><name><surname>Ohana</surname><given-names>B</given-names></name><name><surname>Friedman</surname><given-names>MG</given-names></name><name><surname>Dvoskin</surname><given-names>B</given-names></name><name><surname>Leinonen</surname><given-names>M</given-names></name><name><surname>Boldur</surname><given-names>I</given-names></name></person-group><article-title>Atypical pathogen infection in adults with acute exacerbation of bronchial asthma</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><fpage>406</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">12426232</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emre</surname><given-names>U</given-names></name><name><surname>Roblin</surname><given-names>PM</given-names></name><name><surname>Gelling</surname><given-names>M</given-names></name><name><surname>Dumornay</surname><given-names>W</given-names></name><name><surname>Rao</surname><given-names>M</given-names></name><name><surname>Hammerschlag</surname><given-names>MR</given-names></name><name><surname>Schachter</surname><given-names>J</given-names></name></person-group><article-title>The association of <italic>Chlamydia pneumoniae</italic> infection and reactive airway disease in children</article-title><source>Arch Pediatr Adolesc Med</source><year>1994</year><volume>148</volume><fpage>727</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">8019629</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosentini</surname><given-names>R</given-names></name><name><surname>Tarsia</surname><given-names>P</given-names></name><name><surname>Canetta</surname><given-names>C</given-names></name><name><surname>Graziadei</surname><given-names>G</given-names></name><name><surname>Brambilla</surname><given-names>AM</given-names></name><name><surname>Aliberti</surname><given-names>S</given-names></name><name><surname>Pappalettera</surname><given-names>M</given-names></name><name><surname>Tantardini</surname><given-names>F</given-names></name><name><surname>Blasi</surname><given-names>F</given-names></name></person-group><article-title>Severe asthma exacerbation: role of acute <italic>Chlamydophila pneumoniae</italic> and Mycoplasma pneumoniae infection</article-title><source>Respir Res</source><year>2008</year><volume>9</volume><fpage>48</fpage><pub-id pub-id-type="pmid">18513407</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velissariou</surname><given-names>IM</given-names></name><name><surname>Papadopoulos</surname><given-names>NG</given-names></name></person-group><article-title>The role of respiratory viruses in the pathogenesis of pediatric asthma</article-title><source>Pediatr Ann</source><year>2006</year><volume>35</volume><fpage>637</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">16999297</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papadopoulos</surname><given-names>NG</given-names></name><name><surname>Xepapadaki</surname><given-names>P</given-names></name><name><surname>Mallia</surname><given-names>P</given-names></name><name><surname>Brusselle</surname><given-names>G</given-names></name><name><surname>Watelet</surname><given-names>JB</given-names></name><name><surname>Xatzipsalti</surname><given-names>M</given-names></name><name><surname>Foteinos</surname><given-names>G</given-names></name><name><surname>van Drunen</surname><given-names>CM</given-names></name><name><surname>Fokkens</surname><given-names>WJ</given-names></name><name><surname>D'Ambrosio</surname><given-names>C</given-names></name><name><surname>Bonini</surname><given-names>S</given-names></name><name><surname>Bossios</surname><given-names>A</given-names></name><name><surname>L&#x000f6;tvall</surname><given-names>J</given-names></name><name><surname>van Cauwenberge</surname><given-names>P</given-names></name><name><surname>Holgate</surname><given-names>ST</given-names></name><name><surname>Canonica</surname><given-names>GW</given-names></name><name><surname>Szczeklik</surname><given-names>A</given-names></name><name><surname>Rohde</surname><given-names>G</given-names></name><name><surname>Kimpen</surname><given-names>J</given-names></name><name><surname>Pitk&#x000e4;ranta</surname><given-names>A</given-names></name><name><surname>M&#x000e4;kel&#x000e4;</surname><given-names>M</given-names></name><name><surname>Chanez</surname><given-names>P</given-names></name><name><surname>Ring</surname><given-names>J</given-names></name><name><surname>Johnston</surname><given-names>SL</given-names></name></person-group><article-title>Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document</article-title><source>Allergy</source><year>2007</year><volume>62</volume><fpage>457</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">17324199</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>SP</given-names></name><name><surname>Rosenberg</surname><given-names>HF</given-names></name><name><surname>Moqbel</surname><given-names>R</given-names></name><name><surname>Phipps</surname><given-names>S</given-names></name><name><surname>Foster</surname><given-names>PS</given-names></name><name><surname>Lacy</surname><given-names>P</given-names></name><name><surname>Kay</surname><given-names>AB</given-names></name><name><surname>Rothenberg</surname><given-names>ME</given-names></name></person-group><article-title>Eosinophils: biological properties and role in health and disease</article-title><source>Clin Exp Allergy</source><year>2008</year><volume>38</volume><fpage>709</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">18384431</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>R</given-names></name><name><surname>Humbert</surname><given-names>B</given-names></name><name><surname>Werchau</surname><given-names>H</given-names></name><name><surname>Gallati</surname><given-names>H</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>W</given-names></name></person-group><article-title>Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus</article-title><source>Immunology</source><year>1994</year><volume>82</volume><fpage>126</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">7519169</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piliponsky</surname><given-names>AM</given-names></name><name><surname>Gleich</surname><given-names>GJ</given-names></name><name><surname>Bar</surname><given-names>I</given-names></name><name><surname>Levi-Schaffer</surname><given-names>F</given-names></name></person-group><article-title>Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation</article-title><source>Mol Immunol</source><year>2002</year><volume>38</volume><fpage>1369</fpage><pub-id pub-id-type="pmid">12217410</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>HF</given-names></name><name><surname>Dyer</surname><given-names>KD</given-names></name><name><surname>Domachowske</surname><given-names>JB</given-names></name></person-group><article-title>Respiratory viruses and eosinophils: exploring the connections</article-title><source>Antiviral Res</source><year>2009</year><volume>83</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19375458</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JA</given-names></name></person-group><article-title>Neutrophils, host defense, and inflammation: a double-edged sword</article-title><source>J Leukoc Biol</source><year>1994</year><volume>56</volume><fpage>672</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">7996043</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domachowske</surname><given-names>JB</given-names></name><name><surname>Dyer</surname><given-names>KD</given-names></name><name><surname>Bonville</surname><given-names>CA</given-names></name><name><surname>Rosenberg</surname><given-names>HF</given-names></name></person-group><article-title>Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus</article-title><source>J Infect Dis</source><year>1998</year><volume>177</volume><fpage>1458</fpage><lpage>1464</lpage><pub-id pub-id-type="pmid">9607820</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>HF</given-names></name><name><surname>Domachowske</surname><given-names>JB</given-names></name></person-group><article-title>Eosinophils, ribonucleases and host defense: solving the puzzle</article-title><source>Immunol Res</source><year>1999</year><volume>20</volume><fpage>261</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">10741866</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>HF</given-names></name><name><surname>Domachowske</surname><given-names>JB</given-names></name></person-group><article-title>Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens</article-title><source>J Leukoc Biol</source><year>2001</year><volume>70</volume><fpage>691</fpage><lpage>698</lpage><pub-id pub-id-type="pmid">11698487</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milner</surname><given-names>JD</given-names></name><name><surname>Ward</surname><given-names>JM</given-names></name><name><surname>Keane-Myers</surname><given-names>A</given-names></name><name><surname>Paul</surname><given-names>WE</given-names></name></person-group><article-title>Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>576</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">17202252</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phipps</surname><given-names>S</given-names></name><name><surname>Lam</surname><given-names>CE</given-names></name><name><surname>Mahalingam</surname><given-names>S</given-names></name><name><surname>Newhouse</surname><given-names>M</given-names></name><name><surname>Ramirez</surname><given-names>R</given-names></name><name><surname>Rosenberg</surname><given-names>HF</given-names></name><name><surname>Foster</surname><given-names>PS</given-names></name><name><surname>Matthaei</surname><given-names>KI</given-names></name></person-group><article-title>Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus</article-title><source>Blood</source><year>2007</year><volume>110</volume><fpage>1578</fpage><lpage>1586</lpage><pub-id pub-id-type="pmid">17495130</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Chung</surname><given-names>CY</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>WS</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Koh</surname><given-names>YY</given-names></name></person-group><article-title>Late abnormal findings on high-resolution computed tomography after <italic>Mycoplasma</italic> pneumonia</article-title><source>Pediatrics</source><year>2000</year><volume>105</volume><fpage>372</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">10654958</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>YY</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>CK</given-names></name></person-group><article-title>Levels of interleukin-2, interferon-&#x003b3;, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production</article-title><source>Pediatrics</source><year>2001</year><volume>107</volume><fpage>E39</fpage><pub-id pub-id-type="pmid">11230620</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wongtim</surname><given-names>S</given-names></name><name><surname>Mogmued</surname><given-names>S</given-names></name></person-group><article-title>Methacholine inhalation challenge in patients with post-<italic>Mycoplasma pneumoniae</italic> pneumonia</article-title><source>Asian Pac J Allergy Immunol</source><year>1995</year><volume>13</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">7488345</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabato</surname><given-names>AR</given-names></name><name><surname>Martin</surname><given-names>AJ</given-names></name><name><surname>Marmion</surname><given-names>BP</given-names></name><name><surname>Kok</surname><given-names>TW</given-names></name><name><surname>Cooper</surname><given-names>DM</given-names></name></person-group><article-title><italic>Mycoplasma pneumoniae</italic>: acute illness, antibiotics, and subsequent pulmonary function</article-title><source>Arch Dis Child</source><year>1984</year><volume>59</volume><fpage>1034</fpage><lpage>1037</lpage><pub-id pub-id-type="pmid">6508338</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bufford</surname><given-names>JD</given-names></name><name><surname>Gern</surname><given-names>JE</given-names></name></person-group><article-title>The hygiene hypothesis revisited</article-title><source>Immunol Allergy Clin North Am</source><year>2005</year><volume>25</volume><fpage>247</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">15878454</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strachan</surname><given-names>DP</given-names></name></person-group><article-title>Hay fever, hygiene, and household size</article-title><source>BMJ</source><year>1989</year><volume>299</volume><fpage>1259</fpage><lpage>1260</lpage><pub-id pub-id-type="pmid">2513902</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oddy</surname><given-names>WH</given-names></name><name><surname>de Klerk</surname><given-names>NH</given-names></name><name><surname>Sly</surname><given-names>PD</given-names></name><name><surname>Holt</surname><given-names>PG</given-names></name></person-group><article-title>The effects of respiratory infections, atopy, and breastfeeding on childhood asthma</article-title><source>Eur Respir J</source><year>2002</year><volume>19</volume><fpage>899</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">12030731</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gern</surname><given-names>JE</given-names></name></person-group><article-title>Viral respiratory infection and the link to asthma</article-title><source>Pediatr Infect Dis J</source><year>2008</year><volume>27</volume><fpage>S97</fpage><lpage>S103</lpage><pub-id pub-id-type="pmid">18820588</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yazdanbakhsh</surname><given-names>M</given-names></name><name><surname>Kremsner</surname><given-names>PG</given-names></name><name><surname>van Ree</surname><given-names>R</given-names></name></person-group><article-title>Allergy, parasites, and the hygiene hypothesis</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>490</fpage><lpage>494</lpage><pub-id pub-id-type="pmid">11964470</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romagnani</surname><given-names>S</given-names></name></person-group><article-title>The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?</article-title><source>Immunology</source><year>2004</year><volume>112</volume><fpage>352</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">15196202</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bj&#x000f6;rkst&#x000e9;n</surname><given-names>B</given-names></name><name><surname>Sepp</surname><given-names>E</given-names></name><name><surname>Julge</surname><given-names>K</given-names></name><name><surname>Voor</surname><given-names>T</given-names></name><name><surname>Mikelsaar</surname><given-names>M</given-names></name></person-group><article-title>Allergy development and the intestinal microflora during the first year of life</article-title><source>J Allergy Clin Immunol</source><year>2001</year><volume>108</volume><fpage>516</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">11590374</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Narisawa</surname><given-names>Y</given-names></name><name><surname>Arase</surname><given-names>S</given-names></name><name><surname>Okamatsu</surname><given-names>H</given-names></name><name><surname>Ikenaga</surname><given-names>T</given-names></name><name><surname>Tajiri</surname><given-names>Y</given-names></name><name><surname>Kumemura</surname><given-names>M</given-names></name></person-group><article-title>Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects</article-title><source>J Allergy Clin Immunol</source><year>2003</year><volume>111</volume><fpage>587</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">12642841</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaub</surname><given-names>B</given-names></name><name><surname>Lauener</surname><given-names>R</given-names></name><name><surname>von Mutius</surname><given-names>E</given-names></name></person-group><article-title>The many faces of the hygiene hypothesis</article-title><source>J Allergy Clin Immunol</source><year>2006</year><volume>117</volume><fpage>969</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">16675321</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>AH</given-names></name></person-group><article-title>Endotoxin exposure in allergy and asthma: reconciling a paradox</article-title><source>J Allergy Clin Immunol</source><year>2002</year><volume>109</volume><fpage>379</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">11897980</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gereda</surname><given-names>JE</given-names></name><name><surname>Leung</surname><given-names>DY</given-names></name><name><surname>Thatayatikom</surname><given-names>A</given-names></name><name><surname>Streib</surname><given-names>JE</given-names></name><name><surname>Price</surname><given-names>MR</given-names></name><name><surname>Klinnert</surname><given-names>MD</given-names></name><name><surname>Liu</surname><given-names>AH</given-names></name></person-group><article-title>Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma</article-title><source>Lancet</source><year>2000</year><volume>355</volume><fpage>1680</fpage><lpage>1683</lpage><pub-id pub-id-type="pmid">10905243</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandenburg</surname><given-names>AH</given-names></name><name><surname>Kleinjan</surname><given-names>A</given-names></name><name><surname>van Het Land</surname><given-names>B</given-names></name><name><surname>Moll</surname><given-names>HA</given-names></name><name><surname>Timmerman</surname><given-names>HH</given-names></name><name><surname>de Swart</surname><given-names>RL</given-names></name><name><surname>Neijens</surname><given-names>HJ</given-names></name><name><surname>Fokkens</surname><given-names>W</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name></person-group><article-title>Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity</article-title><source>J Med Virol</source><year>2000</year><volume>62</volume><fpage>267</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">11002258</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaub</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>H&#x000f6;ppler</surname><given-names>S</given-names></name><name><surname>Schleich</surname><given-names>I</given-names></name><name><surname>Huehn</surname><given-names>J</given-names></name><name><surname>Olek</surname><given-names>S</given-names></name><name><surname>Wieczorek</surname><given-names>G</given-names></name><name><surname>Illi</surname><given-names>S</given-names></name><name><surname>von Mutius</surname><given-names>E</given-names></name></person-group><article-title>Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells</article-title><source>J Allergy Clin Immunol</source><year>2009</year><volume>123</volume><fpage>774</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">19348917</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oddy</surname><given-names>WH</given-names></name><name><surname>Holt</surname><given-names>PG</given-names></name><name><surname>Sly</surname><given-names>PD</given-names></name><name><surname>Read</surname><given-names>AW</given-names></name><name><surname>Landau</surname><given-names>LI</given-names></name><name><surname>Stanley</surname><given-names>FJ</given-names></name><name><surname>Kendall</surname><given-names>GE</given-names></name><name><surname>Burton</surname><given-names>PR</given-names></name></person-group><article-title>Association between breast feeding and asthma in 6 year old children: findings of a prospective birth cohort study</article-title><source>BMJ</source><year>1999</year><volume>319</volume><fpage>815</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">10496824</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saarinen</surname><given-names>UM</given-names></name><name><surname>Kajosaari</surname><given-names>M</given-names></name></person-group><article-title>Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old</article-title><source>Lancet</source><year>1995</year><volume>346</volume><fpage>1065</fpage><lpage>1069</lpage><pub-id pub-id-type="pmid">7564787</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>M</given-names></name><name><surname>Ida</surname><given-names>S</given-names></name><name><surname>Takishima</surname><given-names>T</given-names></name></person-group><article-title>Effect of influenza virus infection on allergic sensitization to aerosolized ovalbumin in mice</article-title><source>J Immunol</source><year>1984</year><volume>132</volume><fpage>2614</fpage><lpage>2617</lpage><pub-id pub-id-type="pmid">6715886</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzichini</surname><given-names>MM</given-names></name><name><surname>Pizzichini</surname><given-names>E</given-names></name><name><surname>Clelland</surname><given-names>L</given-names></name><name><surname>Efthimiadis</surname><given-names>A</given-names></name><name><surname>Pavord</surname><given-names>I</given-names></name><name><surname>Dolovich</surname><given-names>J</given-names></name><name><surname>Hargreave</surname><given-names>FE</given-names></name></person-group><article-title>Prednisone-dependent asthma: inflammatory indices in induced sputum</article-title><source>Eur Respir J</source><year>1999</year><volume>13</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">10836317</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jatakanon</surname><given-names>A</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Barnes</surname><given-names>PJ</given-names></name></person-group><article-title>Changes in sputum eosinophils predict loss of asthma control</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>161</volume><fpage>64</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">10619799</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wardlaw</surname><given-names>AJ</given-names></name><name><surname>Brightling</surname><given-names>C</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Woltmann</surname><given-names>G</given-names></name><name><surname>Pavord</surname><given-names>I</given-names></name></person-group><article-title>Eosinophils in asthma and other allergic diseases</article-title><source>Br Med Bull</source><year>2000</year><volume>56</volume><fpage>985</fpage><lpage>1003</lpage><pub-id pub-id-type="pmid">11359633</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanat</surname><given-names>AI</given-names></name><name><surname>Thomson</surname><given-names>JV</given-names></name><name><surname>Radford</surname><given-names>K</given-names></name><name><surname>Nair</surname><given-names>P</given-names></name><name><surname>Sehmi</surname><given-names>R</given-names></name></person-group><article-title>Human airway smooth muscle promotes eosinophil differentiation</article-title><source>Clin Exp Allergy</source><year>2009</year><volume>39</volume><fpage>1009</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">19438586</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haldar</surname><given-names>P</given-names></name><name><surname>Brightling</surname><given-names>CE</given-names></name><name><surname>Hargadon</surname><given-names>B</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Monteiro</surname><given-names>W</given-names></name><name><surname>Sousa</surname><given-names>A</given-names></name><name><surname>Marshall</surname><given-names>RP</given-names></name><name><surname>Bradding</surname><given-names>P</given-names></name><name><surname>Green</surname><given-names>RH</given-names></name><name><surname>Wardlaw</surname><given-names>AJ</given-names></name><name><surname>Pavord</surname><given-names>ID</given-names></name></person-group><article-title>Mepolizumab and exacerbations of refractory eosinophilic asthma</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><fpage>973</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">19264686</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>P</given-names></name><name><surname>Pizzichini</surname><given-names>MM</given-names></name><name><surname>Kjarsgaard</surname><given-names>M</given-names></name><name><surname>Inman</surname><given-names>MD</given-names></name><name><surname>Efthimiadis</surname><given-names>A</given-names></name><name><surname>Pizzichini</surname><given-names>E</given-names></name><name><surname>Hargreave</surname><given-names>FE</given-names></name><name><surname>O'Byrne</surname><given-names>PM</given-names></name></person-group><article-title>Mepolizumab for prednisone-dependent asthma with sputum eosinophilia</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><fpage>985</fpage><lpage>993</lpage><pub-id pub-id-type="pmid">19264687</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Moqbel</surname><given-names>R</given-names></name><name><surname>Lace</surname><given-names>P</given-names></name><name><surname>Adamko</surname><given-names>DJ</given-names></name><name><surname>Odemuyiwa</surname><given-names>SO</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Adkinson</surname><given-names>NF</given-names><suffix>Jr</suffix></name><name><surname>Bochner</surname><given-names>BS</given-names></name><name><surname>Busse</surname><given-names>WW</given-names></name><name><surname>Holgate</surname><given-names>ST</given-names></name><name><surname>Lemanske</surname><given-names>RF</given-names><suffix>Jr</suffix></name><name><surname>Simons</surname><given-names>FE</given-names></name></person-group><article-title>Biology of eosinophils</article-title><source>Allergy: principles &#x00026; practice</source><year>2008</year><publisher-loc>St. Louis</publisher-loc><publisher-name>Mosby</publisher-name><fpage>295</fpage><lpage>310</lpage></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gleich</surname><given-names>GJ</given-names></name><name><surname>Adolphson</surname><given-names>CR</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Sanderson</surname><given-names>CJ</given-names></name></person-group><article-title>The eosinophil and bronchial asthma: evidence for a critical role of eosinophils in pathophysiology</article-title><source>Interleukin-5: from molecule to drug target for asthma (lung biology in health and disease)</source><year>1999</year><publisher-loc>New York</publisher-loc><publisher-name>Marcel Dekker</publisher-name><fpage>1</fpage><lpage>37</lpage></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Ross</surname><given-names>GD</given-names></name><name><surname>Good</surname><given-names>RA</given-names></name><name><surname>Siegal</surname><given-names>FP</given-names></name></person-group><article-title>Surface markers of human eosinophils</article-title><source>Blood</source><year>1976</year><volume>48</volume><fpage>755</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">974267</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ebisawa</surname><given-names>M</given-names></name><name><surname>Schleimer</surname><given-names>RP</given-names></name><name><surname>Bickel</surname><given-names>C</given-names></name><name><surname>Bochner</surname><given-names>BS</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Schlossman</surname><given-names>SF</given-names></name><name><surname>Boumsel</surname><given-names>L</given-names></name><name><surname>Gilks</surname><given-names>W</given-names></name><name><surname>Harlan</surname><given-names>J</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name><name><surname>Morimoto</surname><given-names>C</given-names></name><name><surname>Ritz</surname><given-names>J</given-names></name><name><surname>Shaw</surname><given-names>S</given-names></name><name><surname>Silverstein</surname><given-names>R</given-names></name><name><surname>Springer</surname><given-names>T</given-names></name><name><surname>Tedder</surname><given-names>T</given-names></name><name><surname>Todd</surname><given-names>R</given-names></name></person-group><article-title>Phenotyping of purified human peripheral blood eosinophils using the blind panel mAb</article-title><source>Leucocyte typing V: white cell differentiation antigens: proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993</source><year>1995</year><volume>Volume one</volume><publisher-loc>New York</publisher-loc><publisher-name>Oxford University Press</publisher-name><fpage>1036</fpage><lpage>1038</lpage></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>S</given-names></name></person-group><article-title>Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients</article-title><source>Chest</source><year>2005</year><volume>128</volume><fpage>3148</fpage><lpage>3155</lpage><pub-id pub-id-type="pmid">16304255</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zinchuk</surname><given-names>O</given-names></name><name><surname>Fukushima</surname><given-names>A</given-names></name><name><surname>Zinchuk</surname><given-names>V</given-names></name><name><surname>Fukata</surname><given-names>K</given-names></name><name><surname>Ueno</surname><given-names>H</given-names></name></person-group><article-title>Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis</article-title><source>Mol Vis</source><year>2005</year><volume>11</volume><fpage>114</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">15735601</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Gonzalez-Crussi</surname><given-names>F</given-names></name><name><surname>Hsueh</surname><given-names>W</given-names></name></person-group><article-title>Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora</article-title><source>Immunology</source><year>1999</year><volume>97</volume><fpage>447</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">10447766</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>ER</given-names></name><name><surname>August</surname><given-names>A</given-names></name></person-group><article-title>Eosinophils and allergic airway disease: there is more to the story</article-title><source>Trends Immunol</source><year>2010</year><volume>31</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">19926338</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HB</given-names></name><name><surname>Ghiran</surname><given-names>I</given-names></name><name><surname>Matthaei</surname><given-names>K</given-names></name><name><surname>Weller</surname><given-names>PF</given-names></name></person-group><article-title>Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells</article-title><source>J Immunol</source><year>2007</year><volume>179</volume><fpage>7585</fpage><lpage>7592</lpage><pub-id pub-id-type="pmid">18025204</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duez</surname><given-names>C</given-names></name><name><surname>Dakhama</surname><given-names>A</given-names></name><name><surname>Tomkinson</surname><given-names>A</given-names></name><name><surname>Marquillies</surname><given-names>P</given-names></name><name><surname>Balhorn</surname><given-names>A</given-names></name><name><surname>Tonnel</surname><given-names>AB</given-names></name><name><surname>Bratton</surname><given-names>DL</given-names></name><name><surname>Gelfand</surname><given-names>EW</given-names></name></person-group><article-title>Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge</article-title><source>J Allergy Clin Immunol</source><year>2004</year><volume>114</volume><fpage>820</fpage><lpage>825</lpage><pub-id pub-id-type="pmid">15480321</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welliver</surname><given-names>RC</given-names></name><name><surname>Wong</surname><given-names>DT</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Middleton</surname><given-names>E</given-names><suffix>Jr</suffix></name><name><surname>Vaughan</surname><given-names>RS</given-names></name><name><surname>Ogra</surname><given-names>PL</given-names></name></person-group><article-title>The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection</article-title><source>N Engl J Med</source><year>1981</year><volume>305</volume><fpage>841</fpage><lpage>846</lpage><pub-id pub-id-type="pmid">6168908</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>AM</given-names></name><name><surname>Bonville</surname><given-names>CA</given-names></name><name><surname>Rosenberg</surname><given-names>HF</given-names></name><name><surname>Domachowske</surname><given-names>JB</given-names></name></person-group><article-title>Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation</article-title><source>Am J Respir Crit Care Med</source><year>1999</year><volume>159</volume><fpage>1918</fpage><lpage>1924</lpage><pub-id pub-id-type="pmid">10351940</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SZ</given-names></name><name><surname>Smith</surname><given-names>PK</given-names></name><name><surname>Lovejoy</surname><given-names>M</given-names></name><name><surname>Bowden</surname><given-names>JJ</given-names></name><name><surname>Alpers</surname><given-names>JH</given-names></name><name><surname>Forsyth</surname><given-names>KD</given-names></name></person-group><article-title>Shedding of L-selectin and PECAM-1 and upregulation of Mac-1 and ICAM-1 on neutrophils in RSV bronchiolitis</article-title><source>Am J Physiol</source><year>1998</year><volume>275</volume><fpage>L983</fpage><lpage>L989</lpage><pub-id pub-id-type="pmid">9815117</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>HB</given-names></name><name><surname>Callaway</surname><given-names>Z</given-names></name><name><surname>Shin</surname><given-names>BM</given-names></name><name><surname>Kim</surname><given-names>JT</given-names></name><name><surname>Fujisawa</surname><given-names>T</given-names></name><name><surname>Koh</surname><given-names>YY</given-names></name></person-group><article-title>A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation</article-title><source>J Pediatr</source><year>2010</year><volume>156</volume><fpage>749</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">20171653</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Park</surname><given-names>CS</given-names></name><name><surname>Kim</surname><given-names>BI</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Koh</surname><given-names>YY</given-names></name></person-group><article-title>Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis</article-title><source>J Allergy Clin Immunol</source><year>2003</year><volume>112</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12847481</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehlenfield</surname><given-names>DR</given-names></name><name><surname>Cameron</surname><given-names>K</given-names></name><name><surname>Welliver</surname><given-names>RC</given-names></name></person-group><article-title>Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease</article-title><source>Pediatrics</source><year>2000</year><volume>105</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">10617708</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piippo-Savolainen</surname><given-names>E</given-names></name><name><surname>Remes</surname><given-names>S</given-names></name><name><surname>Korppi</surname><given-names>M</given-names></name></person-group><article-title>Does blood eosinophilia in wheezing infants predict later asthma? A prospective 18-20-year follow-up</article-title><source>Allergy Asthma Proc</source><year>2007</year><volume>28</volume><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">17479599</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigurs</surname><given-names>N</given-names></name><name><surname>Bjarnason</surname><given-names>R</given-names></name><name><surname>Sigurbergsson</surname><given-names>F</given-names></name><name><surname>Kjellman</surname><given-names>B</given-names></name><name><surname>Bj&#x000f6;rkst&#x000e9;n</surname><given-names>B</given-names></name></person-group><article-title>Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls</article-title><source>Pediatrics</source><year>1995</year><volume>95</volume><fpage>500</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">7700748</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frischer</surname><given-names>T</given-names></name><name><surname>Halmerbauer</surname><given-names>G</given-names></name><name><surname>Gartner</surname><given-names>C</given-names></name><name><surname>Rath</surname><given-names>R</given-names></name><name><surname>Tauber</surname><given-names>E</given-names></name><name><surname>Schierl</surname><given-names>M</given-names></name><name><surname>Koller</surname><given-names>DY</given-names></name><name><surname>Urbanek</surname><given-names>R</given-names></name><name><surname>F&#x000f6;rster</surname><given-names>J</given-names></name><name><surname>K&#x000fc;hr</surname><given-names>J</given-names></name></person-group><article-title>Eosinophil-derived proteins in nasal lavage fluid of neonates of allergic parents and the development of respiratory symptoms during the first 6 months of life</article-title><source>Allergy</source><year>2000</year><volume>55</volume><fpage>773</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">10955705</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karawajczyk</surname><given-names>M</given-names></name><name><surname>Pauksen</surname><given-names>K</given-names></name><name><surname>Peterson</surname><given-names>CG</given-names></name><name><surname>Eklund</surname><given-names>E</given-names></name><name><surname>Venge</surname><given-names>P</given-names></name></person-group><article-title>The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections</article-title><source>Clin Exp Allergy</source><year>1995</year><volume>25</volume><fpage>713</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">7584682</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niehaus</surname><given-names>MD</given-names></name><name><surname>Gwaltney</surname><given-names>JM</given-names><suffix>Jr</suffix></name><name><surname>Hendley</surname><given-names>JO</given-names></name><name><surname>Newman</surname><given-names>MJ</given-names></name><name><surname>Heymann</surname><given-names>PW</given-names></name><name><surname>Rakes</surname><given-names>GP</given-names></name><name><surname>Platts-Mills</surname><given-names>TA</given-names></name><name><surname>Guerrant</surname><given-names>RL</given-names></name></person-group><article-title>Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired bacterial sinusitis</article-title><source>J Clin Microbiol</source><year>2000</year><volume>38</volume><fpage>3100</fpage><lpage>3102</lpage><pub-id pub-id-type="pmid">10921988</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosoki</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>A</given-names></name><name><surname>Nagao</surname><given-names>M</given-names></name><name><surname>Hiraguchi</surname><given-names>Y</given-names></name><name><surname>Tokuda</surname><given-names>R</given-names></name><name><surname>Wada</surname><given-names>H</given-names></name><name><surname>Nobori</surname><given-names>T</given-names></name><name><surname>Fujisawa</surname><given-names>T</given-names></name></person-group><article-title>Differential activation of eosinophils by 'probiotic' Bifidobacterium bifidum and 'pathogenic' Clostridium difficile</article-title><source>Int Arch Allergy Immunol</source><year>2010</year><volume>152</volume><issue>Suppl 1</issue><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">20523069</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajagopalan</surname><given-names>G</given-names></name><name><surname>Iijima</surname><given-names>K</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Kita</surname><given-names>H</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>David</surname><given-names>CS</given-names></name></person-group><article-title>Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><fpage>1284</fpage><lpage>1296</lpage><pub-id pub-id-type="pmid">16428778</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>K</given-names></name><name><surname>Kubo</surname><given-names>K</given-names></name><name><surname>Matsuzawa</surname><given-names>Y</given-names></name><name><surname>Sekiguchi</surname><given-names>M</given-names></name></person-group><article-title>Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma</article-title><source>Chest</source><year>1997</year><volume>112</volume><fpage>1241</fpage><lpage>1247</lpage><pub-id pub-id-type="pmid">9367463</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venge</surname><given-names>P</given-names></name><name><surname>Bystr&#x000f6;m</surname><given-names>J</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name><name><surname>H&#x000e2;kansson</surname><given-names>L</given-names></name><name><surname>Karawacjzyk</surname><given-names>M</given-names></name><name><surname>Peterson</surname><given-names>C</given-names></name><name><surname>Sev&#x000e9;us</surname><given-names>L</given-names></name><name><surname>Trulson</surname><given-names>A</given-names></name></person-group><article-title>Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease</article-title><source>Clin Exp Allergy</source><year>1999</year><volume>29</volume><fpage>1172</fpage><lpage>1186</lpage><pub-id pub-id-type="pmid">10469025</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>HF</given-names></name></person-group><article-title>Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>7876</fpage><lpage>7881</lpage><pub-id pub-id-type="pmid">7713881</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehrer</surname><given-names>RI</given-names></name><name><surname>Szklarek</surname><given-names>D</given-names></name><name><surname>Barton</surname><given-names>A</given-names></name><name><surname>Ganz</surname><given-names>T</given-names></name><name><surname>Hamann</surname><given-names>KJ</given-names></name><name><surname>Gleich</surname><given-names>GJ</given-names></name></person-group><article-title>Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein</article-title><source>J Immunol</source><year>1989</year><volume>142</volume><fpage>4428</fpage><lpage>4434</lpage><pub-id pub-id-type="pmid">2656865</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bystrom</surname><given-names>J</given-names></name><name><surname>Amin</surname><given-names>K</given-names></name><name><surname>Bishop-Bailey</surname><given-names>D</given-names></name></person-group><article-title>Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte</article-title><source>Respir Res</source><year>2011</year><volume>12</volume><fpage>10</fpage><pub-id pub-id-type="pmid">21235798</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodruff</surname><given-names>PG</given-names></name><name><surname>Boushey</surname><given-names>HA</given-names></name><name><surname>Dolganov</surname><given-names>GM</given-names></name><name><surname>Barker</surname><given-names>CS</given-names></name><name><surname>Yang</surname><given-names>YH</given-names></name><name><surname>Donnelly</surname><given-names>S</given-names></name><name><surname>Ellwanger</surname><given-names>A</given-names></name><name><surname>Sidhu</surname><given-names>SS</given-names></name><name><surname>Dao-Pick</surname><given-names>TP</given-names></name><name><surname>Pantoja</surname><given-names>C</given-names></name><name><surname>Erle</surname><given-names>DJ</given-names></name><name><surname>Yamamoto</surname><given-names>KR</given-names></name><name><surname>Fahy</surname><given-names>JV</given-names></name></person-group><article-title>Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>15858</fpage><lpage>15863</lpage><pub-id pub-id-type="pmid">17898169</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>RJ</given-names></name><name><surname>Szefler</surname><given-names>SJ</given-names></name><name><surname>King</surname><given-names>TS</given-names></name><name><surname>Kraft</surname><given-names>M</given-names></name><name><surname>Boushey</surname><given-names>HA</given-names></name><name><surname>Chinchilli</surname><given-names>VM</given-names></name><name><surname>Craig</surname><given-names>TJ</given-names></name><name><surname>Dimango</surname><given-names>EA</given-names></name><name><surname>Deykin</surname><given-names>A</given-names></name><name><surname>Fahy</surname><given-names>JV</given-names></name><name><surname>Israel</surname><given-names>E</given-names></name><name><surname>Lazarus</surname><given-names>SC</given-names></name><name><surname>Lemanske</surname><given-names>RF</given-names><suffix>Jr</suffix></name><name><surname>Leone</surname><given-names>FT</given-names></name><name><surname>Pesola</surname><given-names>GR</given-names></name><name><surname>Peters</surname><given-names>SP</given-names></name><name><surname>Sorkness</surname><given-names>CA</given-names></name><name><surname>Szwejbka</surname><given-names>LA</given-names></name><name><surname>Wechsler</surname><given-names>ME</given-names></name></person-group><article-title>The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial</article-title><source>J Allergy Clin Immunol</source><year>2007</year><volume>119</volume><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">17208587</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szefler</surname><given-names>SJ</given-names></name><name><surname>Phillips</surname><given-names>BR</given-names></name><name><surname>Martinez</surname><given-names>FD</given-names></name><name><surname>Chinchilli</surname><given-names>VM</given-names></name><name><surname>Lemanske</surname><given-names>RF</given-names></name><name><surname>Strunk</surname><given-names>RC</given-names></name><name><surname>Zeiger</surname><given-names>RS</given-names></name><name><surname>Larsen</surname><given-names>G</given-names></name><name><surname>Spahn</surname><given-names>JD</given-names></name><name><surname>Bacharier</surname><given-names>LB</given-names></name><name><surname>Bloomberg</surname><given-names>GR</given-names></name><name><surname>Guilbert</surname><given-names>TW</given-names></name><name><surname>Heldt</surname><given-names>G</given-names></name><name><surname>Morgan</surname><given-names>WJ</given-names></name><name><surname>Moss</surname><given-names>MH</given-names></name><name><surname>Sorkness</surname><given-names>CA</given-names></name><name><surname>Taussig</surname><given-names>LM</given-names></name></person-group><article-title>Characterization of within-subject responses to fluticasone and montelukast in childhood asthma</article-title><source>J Allergy Clin Immunol</source><year>2005</year><volume>115</volume><fpage>233</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">15696076</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humbert</surname><given-names>M</given-names></name><name><surname>Menz</surname><given-names>G</given-names></name><name><surname>Ying</surname><given-names>S</given-names></name><name><surname>Corrigan</surname><given-names>CJ</given-names></name><name><surname>Robinson</surname><given-names>DS</given-names></name><name><surname>Durham</surname><given-names>SR</given-names></name><name><surname>Kay</surname><given-names>AB</given-names></name></person-group><article-title>The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences</article-title><source>Immunol Today</source><year>1999</year><volume>20</volume><fpage>528</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">10529782</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>PJ</given-names></name></person-group><article-title>Intrinsic asthma: not so different from allergic asthma but driven by superantigens?</article-title><source>Clin Exp Allergy</source><year>2009</year><volume>39</volume><fpage>1145</fpage><lpage>1151</lpage><pub-id pub-id-type="pmid">19538350</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wark</surname><given-names>PA</given-names></name><name><surname>Gibson</surname><given-names>PG</given-names></name></person-group><article-title>Asthma exacerbations &#x000d7; 3: Pathogenesis</article-title><source>Thorax</source><year>2006</year><volume>61</volume><fpage>909</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">17008482</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Kim</surname><given-names>JT</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Yoo</surname><given-names>Y</given-names></name><name><surname>Koh</surname><given-names>YY</given-names></name></person-group><article-title>Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma</article-title><source>Clin Exp Allergy</source><year>2003</year><volume>33</volume><fpage>1409</fpage><lpage>1414</lpage><pub-id pub-id-type="pmid">14519148</pub-id></element-citation></ref><ref id="B128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>YY</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>CK</given-names></name></person-group><article-title>Ratio of serum eosinophil cationic protein/blood eosinophil counts in children with asthma: comparison between acute exacerbation and clinical remission</article-title><source>Allergy Asthma Proc</source><year>2003</year><volume>24</volume><fpage>269</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">12974194</pub-id></element-citation></ref><ref id="B129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleich</surname><given-names>GJ</given-names></name><name><surname>Adolphson</surname><given-names>CR</given-names></name></person-group><article-title>The eosinophilic leukocyte: structure and function</article-title><source>Adv Immunol</source><year>1986</year><volume>39</volume><fpage>177</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">3538819</pub-id></element-citation></ref><ref id="B130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Yoo</surname><given-names>Y</given-names></name><name><surname>Koh</surname><given-names>YY</given-names></name></person-group><article-title>Bronchoalveolar lavage eosinophil cationic protein and interleukin-8 levels in acute asthma and acute bronchiolitis</article-title><source>Clin Exp Allergy</source><year>2005</year><volume>35</volume><fpage>591</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">15898980</pub-id></element-citation></ref><ref id="B131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HB</given-names></name><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Iijima</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Kita</surname><given-names>H</given-names></name></person-group><article-title>Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum</article-title><source>Chest</source><year>2009</year><volume>135</volume><fpage>295</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">19017877</pub-id></element-citation></ref><ref id="B132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>PG</given-names></name><name><surname>Woolley</surname><given-names>KL</given-names></name><name><surname>Carty</surname><given-names>K</given-names></name><name><surname>Murree-Allen</surname><given-names>K</given-names></name><name><surname>Saltos</surname><given-names>N</given-names></name></person-group><article-title>Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD)</article-title><source>Clin Exp Allergy</source><year>1998</year><volume>28</volume><fpage>1081</fpage><lpage>1088</lpage><pub-id pub-id-type="pmid">9761011</pub-id></element-citation></ref><ref id="B133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morioka</surname><given-names>J</given-names></name><name><surname>Kurosawa</surname><given-names>M</given-names></name><name><surname>Inamura</surname><given-names>H</given-names></name><name><surname>Nakagami</surname><given-names>R</given-names></name><name><surname>Mizushima</surname><given-names>Y</given-names></name><name><surname>Omura</surname><given-names>Y</given-names></name><name><surname>Shibata</surname><given-names>M</given-names></name><name><surname>Chihara</surname><given-names>J</given-names></name></person-group><article-title>Increased END/EPX in ongoing asthma</article-title><source>Allergy</source><year>2000</year><volume>55</volume><fpage>1203</fpage><lpage>1204</lpage><pub-id pub-id-type="pmid">11117285</pub-id></element-citation></ref><ref id="B134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motojima</surname><given-names>S</given-names></name><name><surname>Akutsu</surname><given-names>I</given-names></name><name><surname>Fukuda</surname><given-names>T</given-names></name><name><surname>Makino</surname><given-names>S</given-names></name><name><surname>Takatsu</surname><given-names>K</given-names></name></person-group><article-title>Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma</article-title><source>Allergy</source><year>1993</year><volume>48</volume><fpage>98</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">8109721</pub-id></element-citation></ref><ref id="B135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venge</surname><given-names>P</given-names></name></person-group><article-title>Monitoring the allergic inflammation</article-title><source>Allergy</source><year>2004</year><volume>59</volume><fpage>26</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">14674929</pub-id></element-citation></ref><ref id="B136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Callaway</surname><given-names>Z</given-names></name><name><surname>Fletcher</surname><given-names>R</given-names></name><name><surname>Koh</surname><given-names>YY</given-names></name></person-group><article-title>Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity</article-title><source>J Asthma</source><year>2010</year><volume>47</volume><fpage>568</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">20560830</pub-id></element-citation></ref><ref id="B137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Lee</surname><given-names>KE</given-names></name><name><surname>Kim</surname><given-names>ES</given-names></name><name><surname>Song</surname><given-names>TW</given-names></name><name><surname>Sohn</surname><given-names>MH</given-names></name><name><surname>Kim</surname><given-names>KE</given-names></name></person-group><article-title>Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma</article-title><source>Lung</source><year>2007</year><volume>185</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">17393238</pub-id></element-citation></ref><ref id="B138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniuchi</surname><given-names>S</given-names></name><name><surname>Chihara</surname><given-names>J</given-names></name><name><surname>Kojima</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Sasai</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name></person-group><article-title>Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein</article-title><source>J Dermatol Sci</source><year>2001</year><volume>26</volume><fpage>79</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">11323224</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><p>Infection of bronchial epithelial cells leads to release of mediators, including cytokines, chemokines, and growth factors. Recruited immune cells (eosinophils, neutrophils, and mast cells) release a number of mediators, as well. CCL, CC chemokine ligand; CXCL, CXC chemokine ligand; ECP, eosinophil cationic protein; EDN, eosinophilderived neurotoxin; EPO, eosinophil peroxidase; FGF-2, fibroblast growth factor-2; GM-CSF, granulocyte macrophage-colony stimulating factor; IL, interleukin; LT, leukotriene; MBP, major basic protein; PAF, platelet activating factor; PG, prostaglandin; TNF, tumour necrosis factor; VEGF, vascular endothelial growth factor.</p></caption><graphic xlink:href="apa-2-3-g001"/></fig></floats-group></article>